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Human epidemiological studies have provided compelling evidence that prenatal 
environmental events are associated with significantly increased risks of developing 
neuropsychiatric disorders in adulthood. This phenomenon has been studied and known as 
‘fetal programming of adult diseases’. According to the theory, environmental insults 
occurring at critical periods of pregnancy can permanently alter the structure and physiology 
of the developing organs, and may lead to adverse functional consequences that manifest later 
in life. It has been suggested that increased maternal glucocorticoids may be one common 
mechanism through which various environmental insults can affect on the developing fetus. 
Therefore, in this thesis, I studied the long-term prenatal glucocorticoid overexposure effects 
on the functioning of the brain and investigated possible molecular mechanisms underlying 
the programmed effects. 
 
By using a rat model of prenatal dexamethasone (100μg/kg per day) administered to pregnant 
dams during the last week of gestation, I found that prenatal dexamethasone overexposure 
significantly reduced birth weight in both male and female offspring. I also assessed the 
consequences of prenatal dexamethasone treatment on stress response and cognition in the 
adult male offspring by using a number of physiological and behavioural measures. Overall I 
found no evidence of prenatal dexamethasone treatment effect on the hypothalamic-pituitary-
adrenal (HPA) axis activity and behavioural responsivities to an acute stress in adult male 
offspring; however, prenatal dexamethasone exposure affected hippocampus and prefrontal 
cortex related cognition in the adult offspring, including contextual fear conditioning and 
behavioural flexibility on water maze tasks. I further explored possible molecular mechanisms 
that underlie the behavioural phenotypes of the prenatal dexamethasone rat model, and found 
altered brain gene expression with possible implications in synaptic plasticity and 
retrotransposon activities.  
 xv 
 
Collectively, my current study suggests that prenatal dexamethasone exposure induces long-
term programming effects on adult behaviour, associated with altered gene expression profile 
of the brain in the rat offspring. These results provide further evidence that prenatal 




Environmental adversities during pregnancy are believed to affect the baby’s brain 
development and later mental health. Possible environmental insults range from everyday 
stressful life events to the more severe and rare natural disasters. The prenatal effects on the 
brain may not be apparent at birth, but develop as the child grows. There is evidence that 
children of mothers who experienced higher levels of anxiety during pregnancy are likely to 
have more emotional and behavioural problems, and there is a bigger chance for them to 
develop mental problems when they become adults. How these environmental events affect 
are not yet clear, but effects of maternal stress hormones on the developing fetal brain may be 
one mechanism through which a range of environmental stressors affect the development and 
function of the brain. In clinic, hormone-based treatments are used in several clinical 
conditions during pregnancy. While this therapy has no doubly improved infant health, the 
long-term safety of prescribing hormone in pregnant women is lacking.  
 
In this project I used a rat model to find out the possible long-term impact of prenatal treatment 
of stress hormones on the function of the brain. My results suggest that overexposure to stress 
hormones during pregnancy had an enduring effect on the brain, producing long-term 










Chapter 1 Introduction 
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1.1 Fetal programming of adult diseases 
Environmental factors can act on the genetic constitution of an organism to drive polyphenism, 
a phenomenon that has been studied by biologists since the 19th century. Striking examples 
include developmental and reproductive transitions in plants and animals that are brought 
about by natural selection pressures, such as predators, temperature changes, resource 
availability, chemical pollutants and parasitism. For example, it has been reported that 
developmental temperature induces physiological traits that help an organism to tolerate 
extreme climates (Sinclair et al., 2003). Nutritional availability of the larvae during the first 
three days of life determines the functional differentiation of the honeybee (Weaver, 1955). 
Similarly, a number of factors such as sex hormones, temperature and parasitism are known 
to drive sexual dimorphism in species including invertebrates, fishes, amphibians, birds and 
mammals (Bergerar.J, 1972).  
 
These studies provide important evidence that environmental influence during a specific time 
of development can ‘program’ the end result of phenotype. However, the term ‘programming’ 
was not officially acknowledged until the late 20th century, when Barker first introduced the 
idea of ‘fetal programming of adult diseases’ by showing a link between low birth weight and 
increased deaths from ischaemic heart disease in adulthood (Barker, 1990). The concept of 
‘fetal programming’ is used to describe the fact that early life environmental factors can affect 
fetal development and predict adulthood diseases. According to the theory, environmental 
insults during sensitive periods of development can permanently affect the structure and 
physiology of the developing organs that are concurrently vulnerable, and thus induce lifelong 
consequences on health (Seckl and Holmes, 2007). This kind of developmental plasticity has 
been proposed to help the unborn animal adapt its body systems for better survival in a 
potentially hazardous postnatal environment. However, if a mismatch occurs between the 
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intrauterine environment and the later adulthood environment, such an effort is likely to cause 
maladaptation and result in a higher risk for diseases (Gluckman et al., 2007).  
 
1.1.1 Programming of neuropsychiatric disorders 
Multiple lines of evidence suggest that prenatal environmental factors have programming 
effects on the developing fetus, and that prenatally exposed individuals are at increased risks 
of developing a number of adult diseases in later life. While earlier studies focused 
preferentially on the metabolic and cardiovascular outcomes of intrauterine adversity, more 
recent studies provided evidence that an adverse in utero environment is also predictive of 
adulthood neuropsychiatric disorders, including autism spectrum disorders (ASD), 
schizophrenia and attentional deficit hyperactivity disorder (ADHD) (Kinney et al., 2008b, 
Kinney, 2000, Linnet et al., 2003). These diseases are also called ‘neurodevelopmental 
diseases’, highlighting the fact that altered neural development is involved in the aetiology of 
the disease, and that neuropathological changes exist long before the onset of clinical 
symptoms.  
 
Here I will discuss human epidemiological studies from different parts of the world and 
ethnicities, providing important evidence that a number of prenatal environmental factors are 
associated with increased susceptibility to neuropsychiatric disorders in adulthood.  
 
1.1.1.1 Maternal stressful life events 
In 1976, Ward reviewed data from maternal records of 59 pairs of autistic children and healthy 
children. In his report, 32% of mothers of autistic children (19 out of 59) reported having had 
family discord during the pregnancies, whereas only 2 out of 59 matched control mothers 
reported having experienced discord during their pregnancies (P<0.05) (Ward, 1990). In a 
similar study, researchers surveyed 188 mothers of autistic children and a control group of 202 
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mothers of typical developing children on incidence of stressful life events experienced during 
their pregnancies. The reported presence of stressors during pregnancies was significantly 
higher in the autistic group (32.4 per 100 responses) compared to the control group (25.9 
events per 100 responses; P=0.0007) (Beversdorf et al., 2005). 
 
In another retrospective study, researchers studied the Finnish population register between 
1925 and 1957, and identified an index group of 167 subjects whose fathers had died before 
their children’s births and a control group of 168 subjects whose fathers had died during the 
first year of their children’s lives. It has been found that the number of diagnosed 
schizophrenics was six times higher in the index than in the control group (Huttunen and 
Niskanen, 1978). In another study, Myhrman and colleagues studied the correlation between 
wanted versus unwanted pregnancies and the prevalence of later schizophrenia. Data were 
collected prospectively on 11,017 subjects from the 1966 Northern Finland birth cohort. The 
risk of later schizophrenia was significantly greater (relative risk of 2.4) in subjects born of 
unwanted pregnancies compared to those born of wanted pregnancies (Myhrman et al., 1996).  
 
Two other studies prospectively investigated the association between maternal stress and 
ADHD risks. Van den Bergh and Marcoen (2004) conducted a survey by handing out the State 
Trait Anxiety Inventory to 71 mothers during their pregnancy. Their offspring were followed 
up at age 8 or 9 and ADHD symptoms were rated by the child’s mother, school teacher and an 
external observer. Statistical analysis revealed that maternal anxiety during pregnancy 
accounted for 22%, 15% and 9% of the variance in cross-situational ADHD symptoms, 
externalizing problems and self-reported anxiety, respectively (Van den Bergh and Marcoen, 
2004). In another prospective longitudinal study, researchers followed 290 participants from 
their first antenatal care visit between1992 and 1994 in Uppsala County, Sweden. Maternal 
stress was recorded at different time points during pregnancy and their children were rated at 
7 years old by the mother and school teacher on 18 symptoms related to ADHD according to 
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the DSM-IV criteria. The results indicated that ADHD diagnosis was significantly related to 
prenatal exposure to stress (Rodriguez and Bohlin, 2005).   
 
1.1.1.2 Natural disasters and war 
In one study, Kinney and colleagues studied the prevalence of autism in children that had been 
prenatally exposed to hurricanes and tropical storms that struck Louisiana between 1980 and 
1996. They found that prenatal exposure to storms was significantly associated with increased 
risks of developing autism, and the prevalence of autism increased in a dose-response fashion 
with the severity of storm exposure (Kinney et al., 2008a).  
 
In another study, researchers investigated the prevalence of schizophrenia in birth cohorts that 
had been prenatally exposed to the May 1940 military German invasion of the Netherlands in 
World War II. Individuals whose mothers were pregnant at the time of the invasion were 
identified as the index group, and individuals born in the adjacent two years before or after 
were identified as controls. These cohorts were followed up through the National Psychiatric 
Case Register over the period 1970-1994, and the index group was found to have a significant 
increased risk of lifetime diagnosis of schizophrenia (relative risk 1.15) (van Os and Selten, 
1998).   
 
1.1.1.3 Malnutrition 
Studies also suggest that maternal famine during pregnancy is a risk factor for later 
schizophrenia. The 1944-1945 Dutch Hunger Winter was a time of severe food deprivation 
for the Dutch population following a Nazi blockade in western Holland. By reviewing data on 
population of famine exposure and schizophrenia hospitalization at age 24 and above in the 
exposed and unexposed birth cohorts from the national psychiatric registry, researchers 
reported a significantly increased risk of schizophrenia in birth cohort that had been exposed 
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to the famine during early gestation in both men and women (relative risk 2.0) (Susser et al., 
1996). Similar result was obtained by another group, who studied the effects of the 1959-1961 
famine in the Wuhu region of Anhui, China. The prevalence of schizophrenia was significantly 
increased in cohorts that had been prenatally exposed to the famine, with a mortality-adjusted 
relative risk of 2.30 for those born in 1960 and 1.93 for those born in 1961 (St Clair et al., 
2005). 
 
In summary, converging lines of research suggest that the risk of developing adulthood 
neuropsychiatric disorders is significantly increased following prenatal exposure to various 
environmental insults, including maternal stressful life events, natural disasters, war and 
maternal famine. 
 
1.1.2 Prenatal stress and postnatal abnormalities 
Apart from fully diagnosed neuropsychological diseases, there is evidence that prenatal stress 
can lead to persistent neuropsychological abnormalities that resemble central symptoms of 
neuropsychiatric disorders in humans (Dawson et al., 2000). However, insights from human 
studies have been limited, partly due to the high degree of individual variability and the 
confluence of uncontrolled environmental factors in human studies. Animal studies, on the 
contrary, can establish a direct correlation between prenatal stress exposure and long-term 
postnatal outcomes, when all the other confounding variables are tightly controlled under 
experimental conditions. By directly inducing standardized stress at specific times of gestation 
to the pregnant dams on laboratory animals, these studies have a potential to document a 
diversity of short-term and long-term physiological, behavioural and neurobiological 
outcomes in the offspring.  
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1.1.2.1 Physiological outcomes 
Data from studies using different types of gestational stress in rodents and non-human primates 
indicated that prenatal stress reprograms the hypothalamic pituitary-adrenal (HPA) axis in the 
offspring. HPA axis is the neuroendocrine system that regulates the physiological reaction of 
the body to stress. Despite some inconsistency, the majority of studies report increased 
sensitivity of the HPA axis in the offspring of stressed dams, including increased basal 
secretion and/or enhanced stress-induced secretion of stress hormones (detailed in Chapter 3).  
 
1.1.2.2 Behavioural outcomes 
A large body of evidence suggest prenatal stress induces long-term behavioural changes in 
the offspring (Weinstock, 2008). Animals exposed to stress in utero exhibited increased 
expression of fear and anxiety when challenged with stressful stimuli (Vallee et al., 1997, 
Takahashi et al., 1992, Welberg et al., 2001, Wakshlak and Weinstock, 1990, Clarke et al., 
1996). Offspring of stressed dams were also found to have cognitive deficits, including 
impairments in spatial reference memory (Lemaire et al., 2000, Son et al., 2006, Yang et al., 
2006, Brabham et al., 2000, Markham et al., 2010), working memory (Markham et al., 2010, 
Gue et al., 2004), context- and cue-dependent fear conditioning and extinction (Markham et 
al., 2010, Green et al., 2011b, Wilson et al., 2013). In addition, offspring of stressed dams 
were also found to have reduced attention span, altered motor responses, amplified 
amphetamine self-administration and increased locomotor responses to novelty (Son et al., 
2007, Deminiere et al., 1992, Diaz et al., 1997, Koenig et al., 2005, Schneider et al., 1999). 
 
1.1.2.3 Neurobiological outcomes  
Fear and stress-related pathological changes in prenatally exposed animals have been 
associated with altered functioning of the amygdala (Welberg et al., 2001, Weinstock, 1997), 
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decreased central glucocorticoid receptors expression (Welberg et al., 2001, Henry et al., 
1994, Maccari et al., 1995, Brabham et al., 2000, Levitt et al., 1996) and altered brain 
neurotransmitter systems, including the serotonergic (Huang et al., 2012), dopaminergic (Son 
et al., 2007), catecholaminergic (Takahashi et al., 1992, Green et al., 2011b), cholinergic 
(Emgard et al., 2007), endogenous opioid and GABAergic systems (Weinstock, 1997).  
 
There is also evidence that prenatal stress leads to long-lasting changes in hippocampal 
structure and function, associated with impaired spatial learning and memory in rat 
offspring. The changes include reduced hippocampal weight (Szuran et al., 1994, Mandyam 
et al., 2008), reduced hippocampal neurogenesis (Lemaire et al., 2000) and altered 
hippocampal synaptic plasticity as examined by electrophysiological and biochemical analysis 
(Yang et al., 2006, Son et al., 2006).  
 
Moreover, there is evidence that prenatal exposure to stress during late gestation causes 
male-specific deficits in prefrontal cortex maturation in adolescent rats, associated with 
impaired cognitive behaviours related to prefrontal cortex (Markham et al., 2013). A 
microarray study of the same animal model indicated aberrant expression of genes involved 
in synaptic plasticity in the prefrontal cortex of adult offspring that have been prenatally 
exposed to stress (Kinnunen et al., 2003).  
 
Taken together, the above evidence suggests that intrauterine experience can induce a 
permanent impact on brain structure and function, and affected individuals are at increased 
risks of developing lifetime psychopathological abnormalities.  
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1.1.3 Importance of timing 
The importance of the timing in fetal programming has been suggested by several 
epidemiological studies listed in 1.1.1. These studies suggest that an insult may affect if it 
occurs during certain periods of gestation, and may have little or no effect if it occurs during 
other periods, although different types of insults (maternal anxiety versus maternal famine) 
may act differently if they occur at similar stages of pregnancy. 
 
In the study by Kinney and colleagues, the increased risk for autism was 3.83 times greater in 
children who had been exposed to storms during gestation months 5-6 or 9-10 (equals to weeks 
20-24 or 36-40) compared to children who had been exposed to the same storms, in the same 
place, but during other months of gestation (p < 0.001) (Kinney et al., 2008a). In the study by 
Beversdorf and colleagues, a higher incidence of prenatal stressors was found at 21-32 weeks 
of gestation, with a peak at 25-28 weeks, in the autism cohort (Beversdorf et al., 2005). In the 
Huttunen and Niskanen study for schizophrenia risk, all index subjects were, at the time when 
their fathers died, in weeks 9-20 or 33-40 of gestation (Huttunen and Niskanen, 1978). In the 
May 1940 German invasion of the Netherlands study, incidence of schizophrenia was found 
higher in men and women exposed during the first trimester and in men only exposed during 
the second trimester (van Os and Selten, 1998). In the Dutch hunger study, maternal famine 
during the first trimester was linked to increased risk for schizophrenia (Susser et al., 1996), 
whereas middle to late gestational famine was associated with major affective disorders 
(Brown et al., 2000). In addition, in the Van den Bergh and Marcoen study, maternal anxiety 
during gestational weeks 12-22, but not other gestational weeks, was linked to ADHD risk 
(Van den Bergh and Marcoen, 2004).  
 
Overall the above evidence suggests that stressors during gestational weeks near the middle of 
gestation or before birth are linked to the development of ASD (Kinney et al., 2008a, 
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Beversdorf et al., 2005), exposures during early (van Os and Selten, 1998, Susser et al., 1996), 
middle (van Os and Selten, 1998, Huttunen and Niskanen, 1978) and late gestation (Huttunen 
and Niskanen, 1978) are linked to schizophrenia, whilst second trimester exposure only is 
associated with the development of ADHD (Van den Bergh and Marcoen, 2004). These 
programming windows may represent vulnerable stages and different regions of brain 
development, and perturbations during these sensitive periods may disrupt the normal series 
of developmental events and lead to adverse functional consequences that manifest later in 
life.   
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1.2 Glucocorticoid programming  
There are many hypotheses regarding how the programming effects of prenatal stress 
communicate to the offspring. Theories that have been proposed include a direct action on the 
fetus through mediating factors, or an indirect action by affecting placenta function or 
postnatal maternal behaviour. Among these, fetal exposure to excessive maternal 
glucocorticoids represents one of the most plausible links between prenatal stress and 
increased susceptibility to later on diseases (Seckl and Meaney, 2004).  
 
According to the glucocorticoid programming theory, stress experienced by the pregnant 
mother activates the HPA axis, leading to increased glucocorticoids levels in the maternal 
circulation that may cross the fetoplacental barrier and act on the developing fetus. It has been 
well recognized that other physiological steroids, such as sex hormones, can have 
programming effects on the developing fetus, with an influence that persists throughout life 
(Gustafsson et al., 1983). Thus, glucocorticoids may act in a similar way as ‘programming 
factors’ and have the potential to communicate various environmental stressors to the fetus.  
 
The rationale of glucocorticoid programming can be found a) from the link between low birth 
weight and increased risks of adult diseases and b) from a number of animal studies, which 
provide direct evidence as to the effects of maternal glucocorticoids administration on the 
offspring, as detailed below. 
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1.2.1 Evidence supporting the role of glucocorticoids in programming 
The strongest evidence of glucocorticoid programming comes from the link between low birth 
weight and increased risks of adulthood diseases. The association between low birth weight 
and subsequent development of cardiovascular and metabolic disorders in adulthood was first 
documented by Barker in 1990 (Barker, 1990), and since then found evidence in a number of 
other epidemiological studies (Hales et al., 1991, Law et al., 2002, Leon et al., 1996, Stein et 
al., 1996). In addition, recent evidence indicates that low birth weight is also predictive of an 
increased risk for neuropsychiatric disorders in adult life, including stress-related disorders 
(Lundgren et al., 2001, Nilsson et al., 2004), autism (Pinto-Martin et al., 2011), schizophrenia 
(Abel et al., 2010, Freedman et al., 2013) and ADHD (Breslau et al., 1996). The association 
between low birth weight and adulthood diseases is largely independent of other lifestyle risk 
factors, and are continuous within the normal birth weight range (Barker, 1993, Abel et al., 
2010).  
 
This evidence complements the epidemiological studies discussed in 1.1.1, suggesting that an 
aversive fetal environment may lead to both intrauterine growth restriction and increased 
susceptibility to adulthood diseases. Low birth weight, if considered another phenotype 
programmed by prenatal adversity, supports the role of glucocorticoids in fetal programming. 
In humans, placental 11β-hydroxysteroid dehydrogenase type II (11β-HSD2) catalyses the 
conversion of active glucocorticoids into their inert counterparts and it has been suggested that 
inter-individual variations in 11β-HSD2 activities negatively correlates with the amount of 
glucocorticoid exposed to the fetus (Benediktsson et al., 1995). In supporting the view that the 
amount of maternal glucocorticoids affects offspring birth weight, it has been reported that a 
relative deficiency of term placental 11β-HSD2, with possible overexposure of maternal 
glucocorticoids to the fetus, is associated with reduced birth weight in human offspring 
(Stewart et al., 1995, Edwards et al., 1993). In addition, evidence from human studies shows 
that fetal overexposure to glucocorticoids, either by maternal treatment with synthetic 
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glucocorticoid dexamethasone (a poor substrate for 11β-HSD2) or by maternal consumption 
of licorice, produces not only reduced birth weight, but also long-term alterations in HPA axis 
function, physiological, psychosocial and behavioural outcomes in children and adults (Doyle 
et al., 2000, Hirvikoski et al., 2008, Raikkonen et al., 2010).  
 
A number of animal studies also provide evidence that prenatal administration of 
dexamethasone to pregnant dams can produce phenotypes similar to those in human studies, 
including low birth weight, hypertension, hyperinsulinemia, hyperglycemia, hyperactivity of 
the HPA axis, increased anxiety and altered cognition in the adult offspring (Nyirenda et al., 
1998, Levitt et al., 1996, Brabham et al., 2000, Emgard et al., 2007, Welberg et al., 2001, 
Matthews, 2000, Hauser et al., 2006, Hauser et al., 2008). Conversely, maternal adrenalectomy 
and substitution with corticosterone (CORT) can reverse some of the long-term HPA axis and 
behavioural consequences induced by prenatal stress in the offspring (Barbazanges et al., 
1996, Zagron and Weinstock, 2006). 
 
Taken together, the above evidence lends support to the hypothesis that glucocorticoid 
programming is involved in mediating the link between prenatal stress and risk for adulthood 
diseases.  
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1.2.2 Accessibility of glucocorticoids to the developing fetus 
One important consideration in the context of glucocorticoid programming is the accessibility 
of maternal glucocorticoids to the developing fetus. Under normal physiological conditions 
the fetus is protected from maternal glucocorticoids by the fetoplacenta barrier, which contains 
the enzyme 11β-HSD2 that deactivates most of the maternal glucocorticoids (Seckl and 
Chapman, 1997). However this barrier is not complete, as it has been suggested that there is 
still 10-20% maternal glucocorticoids readily cross the barrier unconverted (Benediktsson et 
al., 1997). Thus, it is possible that excessive maternal glucocorticoids in response to stress-
induced HPA axis activation may pass on to the fetus and interfere with fetal growth and 
development.  
 
1.2.3 Clinical relevance 
Glucocorticoids are prescribed for several conditions in the antenatal clinic. Synthetic 
glucocorticoids, dexamethasone or betamethasone, are used as a prophylactic treatment for 
pregnant women at risk of preterm labour (Liggins and Howie, 1972), and has been proven to 
substantially reduce neonatal mortality (National Institutes of Health Consensus Development, 
2001). Glucocorticoids are also prescribed from early pregnancy if the fetus is at risk for 
congenital adrenal hyperplasia (CAH)(David and Forest, 1984). Long-term or repeated 
glucocorticoids administration is used in chronic conditions such as asthma or rheumatoid 
arthritis in pregnant women. Despite evidence of unequivocal clinical benefits, the potential 
risks related to antenatal use of glucocorticoids need to be evaluated (Fuchs et al., 2014).  
 
There is evidence that antenatal glucocorticoid administration affects birth weight, length and 
head circumference in infant (Khan et al., 2011). In addition, there is increasing concern of the 
long-term consequences of antenatal glucocorticoid therapy. For example, it has been reported 
that late gestational glucocorticoid administration to mothers at risk for preterm labour leads 
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to long-term adverse cardiovascular outcomes in children and adults, including high blood 
pressure and hyperinsulinemia (Doyle et al., 2000, Dalziel et al., 2005). Early dexamethasone 
treatment for CAH has been associated with delayed psychomotor development (Lajic et al., 
1998), psychosocial and behavioural problems in children (Trautman et al., 1995, Hirvikoski 
et al., 2008). Animal studies with rodents and non-human primates also indicate that fetal 
exposure to dexamethasone leads to abnormal development of physiology, motor, affective, 
cognitive and social behaviours in juvenile and adult offspring (Koehl et al., 2001, Matthews, 
2000, Hauser et al., 2008).  
 
Despite possible aversive effects of prenatal dexamethasone exposure indicated by these 
preliminary studies, no firm conclusions have been drawn about the potential risks related to 
antenatal glucocorticoid administration, especially about the life-long cognitive behavioural 
consequences. Given the fact that glucocorticoids are still widely prescribed in antenatal 
practice, it is important to gain more experimental data on the potential long-term 
neurobehavioural consequences of prenatal glucocorticoid exposure in offspring. 
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1.3 Animal models 
In the context of the aforementioned safe use of antenatal glucocorticoids, animal studies 
provide indispensable tools to investigate the long-term neurobehavioral consequences of 
prenatal glucocorticoid overexposure, with the benefit of precise control and manoeuver for 
experimental conditions, such that a correlation or causal relationship can be established. They 
further allow study of the neurobiological mechanisms that underlie behavioural phenotypes, 
with the potential of unravelling novel pharmacological therapies for treatment.  
 
In this project, I used a rat model of dexamethasone (Dex) administered to pregnant dams 
during the last week of gestation. The construction of this animal model is based on the link 
between prenatal stress and increased risks of adulthood neuropsychiatric disorders from 
human epidemiological studies (detailed in 1.1) and its possible association with fetal 
overexposure to excessive maternal glucocorticoids (detailed in 1.2).   
 
I will first discuss the construct validity of this animal model, with regards to the timing of 
exposure and glucocorticoids actions. I will then discuss the face validity of this animal model, 
by examining the phenomenological similarities between the reported phenotypes of this 
model and relevant clinical conditions.  
 
1.3.1 Construct validity 
I discussed the importance of timing in fetal programming in 1.1.3, it is thus crucial to consider 
the time of exposure when constructing an animal model. The animal model used in my current 
project is to give pregnant dams Dex injections during the last week of gestation, E15-21 
inclusive. The rationale of choosing this time is firstly based on the evidence discussed in 
1.1.3, such that stressors during the second trimester of human gestation is most strongly 
associated with the development of adulthood neuropsychiatric disorders. However there are 
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considerable differences in development timetables between humans and other mammalian 
species, and it has been suggested that the second stage of human gestation is mostly identical 
to E14-21 in rats in terms of brain development (Clancy et al., 2007). In addition, previous 
study shows that prenatal dexamethasone administration to pregnant dams induced 
programming effects on offspring physiology only when given during the last week of 
gestation, and no effect was observed when dexamethaosne was given during the first or the 
second gestational week (Nyirenda et al., 1998). Another consideration is the accessibility of 
Dex to the fetal brain in rats. Dex is a poor substrate for 11-HSD2, which means it can readily 
cross the fetoplacental barrier (detailed in 1.2.2), and in a similar way bypasses the tissue 
specific 11-HSD2 expressed in the fetal brain. However the action of Dex on the fetal brain 
still depends on the local expression of its receptors. It has been suggested that Dex binds to 
glucocorticoid receptor (GR) at the experimental dose of 0.1mg/kg, and there is evidence that 
GR mRNA is expressed in the fetal brain from E12.5 in rats, whereupon its expression 
increases throughout gestation in different parts of the fetal brain (Diaz et al., 1998).  
 
In summary, the construction of this animal model allows us to study the long-term 
behavioural and neurobiological effects of fetal overexposure to glucocorticoids, and to 
investigate the potential role of glucocorticoids in fetal programming of adult neuropsychiatric 
disorders.  
         
1.3.2 Face validity  
The phenomenological similarities between an animal model and relevant clinical conditions 
are measured by face validity, which is essential for extrapolating any knowledge derived from 
the model system to human conditions.  
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Several previous studies have investigated the cardiovascular and metabolic consequences of 
this model system, producing robust evidence of low birth weight, hypertension, and glucose 
intolerance in the adult offspring (Nyirenda et al., 1998, Levitt et al., 1996). These phenotypes 
are analogous to the cardiovascular and metabolic conditions that have been associated with 
prenatal stress in human patients (Khulan and Drake, 2012). Thus, this modelling proves a 
potential tool for studying some aspects of the cardiovascular and metabolic consequences of 
prenatal glucocorticoid programming.  
 
In addition, it has been shown that this model system elicits neuroendocrine and behavioural 
phenotypes that resemble neuropsychiatric endophenotypes in the adult offspring, including 
HPA axis hypersensitivity, increased expression of fear and anxiety, reduced coping and 
learning in aversive situations (Weinstock, 1997, Welberg et al., 2001). The relevance of these 
phenotypes to clinical human conditions needs further validation, and the prenatal 
glucocorticoids effects on other aspects of cognitive function have not yet been explored.   
 
In the current project, I aimed to further investigate the emotional and behavioural 
consequences of prenatal Dex exposure by using this rat model, and thus to investigate the 
face validity of using this model system for studying some of the related psychopathology 
changes in the context of prenatal glucocorticoid programming.   
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1.4 Epigenetics  
Accumulating evidence suggests that an adverse early life experience is associated with 
increased susceptibility to diseases in adulthood, however the mechanisms of how these 
prenatal effects are established and sustained are not yet well understood. Recent studies 
suggest epigenetic mechanisms may provide a plausible link between early life adversity and 
sustained alterations in gene expression that lead to disease phenotypes in adults (Jirtle and 
Skinner, 2007).  
 
The term ‘epigenetics’ was first coined by Conrad Waddington in the 1940s, in his study of 
the relationship between genes and their phenotypic products during embryological 
development (Waddington, 1968). He used this term to refer to things happening beyond the 
gene itself, addressing the fact that genetic variations do not always couple with phenotypic 
variations (Waddington, 1953). The concept has not changed much over the subsequent half a 
century, focusing largely on studies of cellular differentiation during embryonic development, 
of the temporal and spatial control of gene expression that gives rise to the various cellular 
phenotypes from the same genotype (Jablonka and Lamb, 2002). A real change in the scope 
of epigenetics took place when the molecular mechanisms controlling gene expression became 
clear, and when the dynamic nature of epigenetics began to be recognized. Epigenetics today 
refers to the mitotically and/or meiotically heritable, but reversible modifications of gene 
expression that are not encoded by the primary DNA sequence itself, encompassing a diversity 
of phenomena in addition to cellular differentiation, such as X-chromosome inactivation in 
females, repression of transposons and parent of origin specific expression of imprinted genes 
(Jablonka and Lamb, 2002, Goldberg et al., 2007).  
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1.4.1 Molecular mechanisms of epigenetics  
There are several molecular mechanisms involved in epigenetics, including DNA methylation, 
histone modifications, non-coding RNA and chromatin conformation changes. Epigenetic 
modifications through these mechanisms can affect the expression of genes.  
 
DNA methylation is by far the best-characterized mechanism of epigenetic regulation in the 
mammalian genome. It involves the transfer of a methyl group onto the 5’-position of the 
cytosine nucleotide, mostly in the context of Cytosine-phosphate-Guanine (CpG) 
dinucleotides at CG-rich gene regulatory regions. DNA methylation at the 5′ promoter regions 
of genes is the most extensively studied mechanism of transcriptional silencing of genes, either 
by reducing the accessibility of transcription factors to their binding sites, or through 
recruitment of methyl-CpG binding domain-containing proteins (MBDs), which, together with 
histone modification complexes, lead to chromatin structure remodelling and subsequent 
transcriptional repression (Nan et al., 1998).  
 
Histone modifications including acetylation, methylation, phosphorylation ubiquitination and 
sumoylation are also involved in transcriptional control of gene expression by affecting 
chromatin accessibility (Bannister and Kouzarides, 2011). Non-coding RNAs (ncRNAs), 
including long ncRNAs (lncRNAs) (longer than 200 nucleotides) and short ncRNAs (<200 
nucleotides long), have also been implicated in various epigenetic regulatory processes 
(Mattick and Makunin, 2006, Zhou et al., 2010). For example, there is evidence that lncRNAs 
are involved in recruiting DNA methyltransferases (DNMT), histone modifying enzymes and 
chromatin remodelling complexes to their sites of action (Zhou et al., 2010). Short ncRNAs, 
including microRNAs (miRNAs) and small interfering RNAs (siRNAs) are also involved in 
epigenetic regulation of gene expression through transcriptional silencing and post-
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transcriptional silencing, such as translational repression and RNA interference (Chu and 
Rana, 2007). 
 
1.4.2 The dynamic nature of epigenetics 
Epigenetic marks are thought to be established during development and subsequently retained 
through mitosis, promoting cellular identity in future cell generations. For a long time, these 
epigenetic marks have been regarded as predominantly irreversible, however in recent years it 
has been recognized that epigenetic marks are dynamic and continuously responsive to 
genetic, environment and stochastic factors even in fully differentiated mature cells (Feil and 
Fraga, 2011). I here discuss evidence that epigenetic marks are modifiable during 
embryogenesis and through adulthood, and that they may serve as an interface between genetic 
traits and environmental factors.  
 
1.4.2.1 Embryogenesis  
During embryogenesis, the epigenetic signatures of the mammalian genome (epigenome) 
undergo precise, coordinated reprogramming at distinct stages of development (Seisenberger 
et al., 2013).  
 
Mouse studies suggest there are two global DNA demethylation and subsequent re-
methylation events during mammalian development. The first wave of DNA demethylation 
happens immediately following fertilization in the zygote, with important exceptions in 
imprinted genes, active retrotransposons and heterochromatin regions, for the benefit of 
maintaining parental imprinting, transposon repression and chromosomal stability, 
respectively (Seisenberger et al., 2013). Remethylation follows, progressively generating 
epigenetic marks that reflect cellular lineage decisions and the developmental history of the 
embryo (Seisenberger et al., 2013). 
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In order to give rise to gametes, the primordial germ cells (PGCs) undergo a second wave of 
DNA demethylation to erase their somatic epigenetic patterns. The erasure of DNA 
methylation in PGCs appears to start from approximately E8.0 and completes by 
approximately E13.5 (Rose et al., 2013). The following wave of remethylation is sex-specific. 
It is believed to initiate at around E15 in male germ cells and occur after birth in the growing 
oocytes in female germ cells (Rose et al., 2013). This second wave of epigenetic 
reprogramming resets most DNA methylation marks including parental imprints to reflect the 
gender of the embryo.  
 
These developmental reprogramming events are characterized by remarkable changes of 
epigenetic marks, which may render these time points more susceptible to environmental 
perturbations compared to the fully differentiated state. Evidence of environmental influence 
on the epigenome during development is discussed below in 1.4.3.  
 
1.4.2.2 Adulthood 
Although embryogenesis represents a time of increased vulnerability, the environment can 
impact on the epigenome in postnatal life as well. Direct evidence comes from studies in 
monozygotic twins, who were found to be epigenetically indistinguishable during the early 
years of life, but who developed remarkably different epigenetic traits in their older age (Fraga 
et al., 2005). In adults, the dynamic nature of the epigenome is evident in a variety of 
physiological processes such as hippocampal neurogenesis, neuroplasticity and memory 
formation. In addition, there is direct evidence that various environmental factors such as 





In adults, there are still thousands of new neurons generated from neural stem cells in discrete 
regions of the mammalian brain every day. Adult neurogenesis, the generation of functional 
neural cell types from adult neural stem cells, is dynamically regulated by epigenetic 
mechanisms and is in response to a variety of internal physiological, environmental and 
experience-dependent clues (Ma et al., 2010).  
 
Neuronal plasticity and memory formation 
Epigenetic mechanisms are implicated in experience-dependent learning and memory 
formation (Day and Sweatt, 2011). For example, it has been reported that DNA methylation 
and histone acetylation are dynamically regulated in the adult brain in response to experience 
(Levenson et al., 2006), and that they are involved in the induction of synaptic plasticity and 
memory formation and maintenance (Day and Sweatt, 2010, Levenson et al., 2004, Levenson 
et al., 2006). There is also evidence that environmental factors such as stress and hormones 
can influence epigenetic processes, leading to altered neural function and memory formation 
(Feng et al., 2007). 
 
Exposure to environmental factors 
Increasing evidence suggests that exposure to various environmental toxicants can induce 
phenotypic changes in epigenetic patterns during the lifetime. For example, tobacco smoking 
has been associated with altered DNA methylation at promoter regions of several tumour 
suppressor genes in the bronchial epithelial cells (Belinsky et al., 2002). Global DNA 
methylation changes were found in blood cells of individuals exposed to the carcinogen 
benzene (Bollati et al., 2007) and air pollutants (Baccarelli et al., 2009). Chronic exposure to 
sunlight has been shown to induce epigenetic changes in skin cells (Gronniger et al., 2010). 
Epigenetic changes in brain reward regions have been implicated in the pathogenesis and 
persistence of drug addiction (Renthal and Nestler, 2008). Likewise, exposure to chronic stress 
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is believed to induce phenotypic epigenetic changes across multiple generations (Skinner, 
2014). 
 
In conclusion, the dynamic nature of the epigenome can be seen in a variety of physiological 
and pathological processes along the history of life, and epigenetic traits may be modifiable 
and responsive to environmental stimuli irrespective of the stage of development.  
 
1.4.3 Epigenetics and programming 
As discussed in 1.4.2.1, the developmental period is a time of particular vulnerability to 
epigenetic perturbations, as active changes in epigenetic marks are taking place as part of 
developmental reprogramming and subsequent cellular lineage differentiation. Environmental 
influence on the epigenome during development can be maintained through subsequent cell 
divisions, and thus induce an enduring impact on later life.   
 
1.4.3.1 Prenatal effects 
A number of animal studies and human data have documented that prenatal environmental 
factors, such as maternal diet, maternal exposure to stress and maternal glucocorticoids 
administration during pregnancy can modulate the epigenetic signatures of the offspring, 
accompanied by sustained alterations in gene transcription and phenotype.  
 
Diet 
It has been reported that exposure to a low-protein diet during pregnancy in rats leads to altered 
epigenetic regulation and gene expression of the peroxisomal proliferator-activated receptor 
(Ppar) gene, which encodes a product involved in lipid homeostasis, in the liver of rat 
offspring after weaning (Lillycrop et al., 2005). Similarly, a maternal low-protein diet has been 
associated with epigenetic silencing of the hepatic nuclear factor 4α (Hnf4α) gene with 
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associated decrease in gene expression in the pancreatic islets of rat offspring, which has been 
linked to the development of type 2 diabetes in the same animal model (Sandovici et al., 
2011). In addition, dietary restriction during early development has been found to cause 
widespread alterations in DNA methylation in the fetal liver in sheep, associated with altered 
immune responses to antigenic challenge, insulin-resistance and elevated blood pressure in 
adults (Sinclair et al., 2007). Studies on the Dutch hunger cohort have provided the first human 
evidence that maternal famine during early gestation leads to persistent changes in DNA 
methylation at genes related to growth and metabolic diseases, such as insulin-like growth 
factor 2 (IGF2), insulin (INS), guanine nucleotide binding protein a-stimulating (GNAS) and 
maternally expressed gene 3 (MEG3) (Tobi et al., 2009, Heijmans et al., 2008).  
 
Maternal stress 
There is evidence that prenatal stress induces epigenetic changes on a number of candidate 
genes likely to be implicated in neuropsychiatric disorders, including glutamic acid 
decarboxylase (GAD67), reelin and brain-derived neurotrophic factor (BDNF). One study 
reported that maternal restraint stress in mice leads to overexpression of DNA 
methyltransferase 1 (Dnmt1) in GABAergic neurons, resulting in hypermethylation at the 
promoter regions of Gad67 and reelin, associated with decreased mRNA expression of 
relevant genes in early and adult life (Matrisciano et al., 2013). Similarly, another study 
reported that prenatal stress leads to decreased cortical expression of reelin in rat fetuses, 
accompanied by hypermethylation at the gene promoter region. These molecular changes are 
associated with persistent behavioural consequences in adults, including increased 
spontaneous locomotor activity, higher anxiety levels and cognitive deficits (Palacios-Garcia 
et al., 2015). A recent study also reported decreased expression of Bdnf transcripts in the 
prefrontal cortex and hippocampus of prenatally stressed mice, associated with increased 
expression of Dnmt1 and hypermethylation at the Bdnf gene regulatory regions (Dong et al., 
2015). In another study, researchers found increased levels of DNMT1 protein in the 
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hippocampus of prenatally exposed mice, associated with impaired performance in water maze 
test (Benoit et al., 2015). In addition, evidence from human studies indicated that maternal 
stress during pregnancy is associated with DNA methylation changes at differentially 
methylated regions (DMRs) of imprinted genes, including mesoderm specific transcript 
(MEST) (Vidal et al., 2014), MEG3 and IGF2 (Liu et al., 2012). 
 
Glucocorticoid exposure 
It has been reported that Dex administration during the last week of gestation in rats is 
associated with decreased DNA methylation at one of the DMRs of Igf2 in the fetal liver 
(Drake et al., 2011). Studies with guinea pigs also suggested that glucocorticoids treatment 
during late gestation induces genome wide changes in promoter DNA methylation and histone 
acetylation in the fetal hippocampus (Crudo et al., 2013). The same group of researchers also 
reported changes in the developmental trajectory of DNA methylation in several other fetal 
tissues of prenatally exposed guinea pigs, associated with altered expression of genes involved 
in DNA methylation process (Crudo et al., 2012). 
 
1.4.3.2 Postnatal effects  
After birth, the prepubertal brain still undergoes remarkable changes in both structure and 
function and is therefore vulnerable to remodelling by environmental factors (Romeo and 
McEwen, 2006). There is evidence that the impact of postnatal experience on brain function 
may be partly mediated by long-lasting epigenetic changes in the offspring, as discussed 
below.   
 
The first report in this field was made by Weaver by showing that low levels of maternal care 
in rats is associated with hypermethylation at regulatory regions of GR (also known as Nr3c1), 
leading to reduced binding of a transcription factor, nerve growth factor inducible gene-A 
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(NGFI-A), and subsequent decrease in hippocampal GR expression (Weaver et al., 2004). 
Similar findings were reported in humans, for example childhood abuse has been associated 
with hypermethylation at NGFI-A binding site of the NR3C1 promoter region, with associated 
reduction in hippocampal GR expression in adult suicidal victims (McGowan et al., 2009).  
 
Possible implications of other candidate genes have also been reported, including genes 
involved in the HPA axis regulation, genes associated with cognitive and emotional behaviour 
and genes involved in epigenetic processes. For example, one study reported early life stress 
causes persistent hypomethylation at an important regulatory region of the arginine 
vasopressin (Avp) gene in the paraventricular nucleus  (PVN) of exposed mice, with functional 
and phenotypic relevance of increased Avp expression, increased HPA axis activity and 
behavioural alterations (Murgatroyd et al., 2009). Another study reported site-specific 
hypermethylation at the Bdnf promoter region, with functional relevance of decreased Bdnf 
expression in the prefrontal cortex of rat offspring of chronically stressed mothers (Roth et al., 
2009). In another study, maternal separation leads to altered DNA methylation patterns in the 
promoter regions of several candidate genes in the germline cells of mice offspring, including 
methyl CpG-binding protein 2 (Mecp2), cannabinoid receptor-1 (Cnr1) and corticotrophin-
releasing hormone receptor 2 (Crhr2). These changes in methylation are functionally related 
to altered levels of mRNA expression, and can be maintained and passed on to the next 
generation (Franklin et al., 2010). Another recent study also reported that mild adolescence 
separation stress in mice with genetic risks leads to DNA hypermethylation of the tyrosine 
hydroxylase (Th) gene in dopaminergic neurons, associated with several neurochemical and 
behavioural deficits in offspring (Niwa et al., 2013).  
 
In addition, there is also evidence that the impact of postnatal experience on DNA methylation 
is both genome-wide and system-wide. For example, one study reported that different 
postnatal rearing conditions lead to genome-wide alterations in promoter methylation in the 
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prefrontal cortex of rhesus monkeys. DNA methylation changes are not limited to the brain, 
but are also evident in the peripheral T cells (Provencal et al., 2012). Similarly, childhood 
abuse is associated with genome-wide changes in promoter methylation in the adult 
hippocampus of suicidal victims, with functional relevance of altered gene expression 
involved in cellular/neuronal plasticity (Labonte et al., 2012).  
 
In summary, these studies provide important evidence that epigenetic changes are involved in 
the long-term pathological trajectories predisposed by early life environmental events, lending 
support to the hypothesis that epigenetic mechanisms may be implicated in the fetal 
programming of adult diseases.  
 
1.4.4 Epigenetics and neuropsychiatric disorders 
Important efforts have been made to elucidate the molecular basis underlying human 
neuropsychiatric conditions. Increasing evidence suggests that epigenetic mechanisms are 
involved in mediating the long-lasting alterations in brain function in neuropsychiatric 
disorders (Tsankova et al., 2007).  
 
Direct evidence supporting the role of epigenetics in neuropsychiatric disorders comes from 
genome-wide scans which revealed significant changes in DNA methylation status of single 
loci candidate genes as well as global changes in epigenetic landscapes between psychiatric 
patients and healthy controls, using DNA samples extracted from human post-mortem brain 
and blood leukocytes samples. Evidence was found in an array of neuropsychiatric disorders, 
including schizophrenia (Grayson et al., 2005, Carrard et al., 2011, Liu et al., 2014), ASD 
(Nguyen et al., 2010) and bipolar disorders (Mill et al., 2008, Carrard et al., 2011). In addition, 
epigenetic-related processes, such as adult neurogenesis (Hsieh and Eisch, 2010), 
retrotransposition and genomic imprinting (detailed in chapter 6), have been implicated in 
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neuropsychiatric disorders, providing further evidence that epigenetic mechanisms may be 
involved in the pathogenesis of neuropsychiatric disorders.  
 
Detailed reviews of our current knowledge regarding the epigenetic mechanisms involved in 
common neuropsychiatric disorders such as ASD, schizophrenia and bipolar disorders can be 
found in some good reviews (Labrie et al., 2012, Siniscalco et al., 2013). Together with 
existing evidence of epigenetics in programming (discussed in 1.4.3), it is very likely that 
epigenetic regulatory mechanisms may represent a link between prenatal environmental 
factors and subsequent long-term impact on mental health in adult life. 
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1.5 Hypotheses and aims 
I hypothesise that intrauterine overexposure to glucocorticoids will induce programming 
effects on brain development and function in the offspring, the effects of which may endure 
into adult life and affect later mental health.  
 
This study is aimed at exploring possible effects of prenatal glucocorticoid overexposure on 
the functioning of the brain and to investigate possible molecular mechanisms underlying the 
prenatal glucocorticoid programming effects. By using a rat model of prenatal Dex treatment 
during the last week of gestation, I will explore the effects of prenatal glucocorticoid 
overexposure on fetal growth as well as the long-term programming effects on stress response 
and cognition. I will also explore the molecular basis underlying the behavioural phenotypes 
of the prenatal Dex exposure model by studying the expression of candidate genes known to 
be involved in relevant behaviour. Finally, considering the plausible role of epigenetics 
involved in prenatal programming, I will therefore study the effects of prenatal glucocorticoid 
overexposure on brain expression of candidate genes involved in two epigenetically regulated 
processes such as retrotransposon activities and genomic imprinting. An outline of 
experiments involved in this thesis is listed below.   
 
 31 
1.6 Outline of experiments 
The content of my current study include: 
Chapter 3   
Basal and stress-induced plasma CORT levels  HPA axis activity 
Elevated plus-maze  Unconditioned fear and anxiety-related behaviour  
Open field  Unconditioned fear and anxiety-related behaviour  
Contextual fear conditioning 
 
 Unconditioned fear and anxiety-related behaviour  




Spatial reference memory with reversal learning  Spatial reference memory 
Within-task behavioural flexibility 
Delayed matching to position (DMTP)  Working memory 
Within-task behavioural flexibility 
Intra/Extra-dimensional (ID/ED) attentional set-shifting   Behavioural flexibility within attentional settings 
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Chapter 5  
  
Brain gene expression  Candidate genes involved in behaviour 
Validation of next generation RNA Sequencing (RNA-Seq) data on adult prefrontal 
cortex (PFC) samples 




Brain gene expression  Candidate genes including retrotransposons and imprinted genes 
DNA methylation at DMRs of imprinted Dlk1-Dio3 and 
Igf2 regions 











Chapter 2 Materials and methods 
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2.1  Buffers and Solutions 
Room temperature (RT°) is defined as 18-25°C. 
 
0.5M EDTA (pH 8.0): Disodium ethylenediaminetetraacetate.2H2O (186.1g) was dissolved 
in 800ml of Milli-Q water. pH was adjusted to 8.0 by adding 10M KOH and the final volume 
was adjusted to 1L with Milli-Q water. The buffer was sterilized in an autoclave and kept at 
RT°. 
 
DEPC-treated water: 7 drops of Diethyl pryrocarbonate (DEPC) was added to 500ml of Milli-
Q water. The container was vigorously shaken and left at RT° in the fume hood overnight 
before being autoclaved.  
 
10x TBE Buffer: Tris base (108g), boric acid (55g) and 40ml of 0.5M EDTA were dissolved 
in 800ml of Milli-Q water. pH was adjusted to 8.0 by adding 10M KOH and the final volume 
was adjusted to 1L with Milli-Q water. The buffer was autoclaved and kept at RT°. 
 
0.5x TBE Buffer: 50ml of 10x TBE was diluted in 950ml of Milli-Q water and stored at RT°. 
 
Chaos Buffer: Guanidinium thiocyanate (53.2g), N-lauroylsarcosine (sarcosyl)  (2.0g) and 
10ml of 0.5M EDTA (pH8.0) were dissolved in DEPC water, and the final volume was 
adjusted to 100ml. The buffer was filtered and kept at RT°. 0.1M 2-mercaptoethanol (14.33 




2.2 Animal maintenance 
All animal procedures were carried out under project license number 60/3962 and 70/7870 
and personal license number 60/13373 under the terms of the Animals (Scientific Procedures) 
Act 1986. William Mungall and Richard Watson were responsible for the daily maintenance 
of rats in the Biomedical Research Facility (BRF) Little France facility and BRF 1 George 
Square facility, respectively. All experiments were performed in accordance with the UK 
Animals (Scientific Procedures) Act 1986 and were conducted strictly according to local ethics 
guidelines to minimize animal suffering and the number of animals to be used.  
 
Wistar rats were bought from Charles River UK. Female and male rats were purchased for 
mating at 2 months old. Animals had ad libitum access to food (standard rat chow, RM1, 
Special Services Diet, Lillico, Surrey, UK) and water. Rats were maintained under controlled 
temperature (between 19 and 21°C) and light/dark cycle (lights on from 07:00 to 19:00) in 
both units. Rats were kept at a maximum of five per cage and cages were cleaned weekly. 
 
Rats were allowed to acclimatize for two weeks after arrival at the BRF. At mating, a female 
was housed individually with a male of similar age. Following vaginal plugging (denoted as 
E1) pregnant dams were randomly assigned to Dex or vehicle (Con) treatment. From E15-E21 
inclusive, dams were given a daily subcutaneous injection of either Dex (100μg/kg body 
weight, dissolved in 4% ethanol, 0.9% saline) or an equivalent volume of vehicle (4% ethanol, 
0.9% saline) (0.5ml/kg). At birth (postnatal day 1), the offspring (Dex or Con) were weighed, 
sexed and litters culled back to eight per group, leaving 5 males and 3 females per litter where 
possible. Pups were reared by their biological mothers until weaning at three weeks of age, 
whereupon female offspring were culled and male pups were housed in same treatment groups. 
Animals were then left undisturbed until adulthood.  
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2.3 Molecular procedures 
2.3.1 Tissue collection  
Animals from each group were taken from their home cage and killed by exposure to a rising 
concentration of carbon dioxide followed by decapitation following loss of consciousness. 
Brains were immediately removed and immediately dissected into five parts, namely 
prefrontal cortex (PFC), hippocampus, hypothalamus, cerebellum and the rest of brain. For 
adult brain tissues, each part of the brain was kept separately as left and right. Dissected tissues 
were snap frozen on dry ice and stored at -80°C. 
 
2.3.2 Simultaneous RNA/DNA extraction 
Total genomic DNA and RNA were extracted from individual dissected brain samples. 
Approximately 30mg of frozen brain tissue was used for the simultaneous extraction of total 
genomic RNA and DNA. Each individual sample was homogenized in short bursts in 800μl 
Chaos Buffer. The homogenate was immediately divided in half and used for RNA or DNA 
extraction.   
 
RNA extraction was conducted immediately after homogenization to avoid degradation. 40μl 
2M sodium acetate, 400μl acidic phenol (pH4.2) and 200μl chloroform/isoamyl-ethanol were 
added to the homogenate. Samples were incubated on wet ice for 10 min and then centrifuged 
at full speed for 20 min at 4°C. An equal volume of 100% isopropanol was added to the upper 
phase, and the mixture was then transferred to a Qiagen RNeasy spin column (RNeasy® mini 
kit, Qiagen). All samples were then washed following the manufacturer’s protocols and were 
eluted in a final volume of 30μl RNase-free water. For adult PFC samples prepared for next 
generation sequencing, a RNeasy® plus mini kit was used (Qiagen) and manufacturer’s 
protocols followed.  
 
 37 
The allocated portions for DNA extractions were kept on wet ice while waiting for the RNA 
extraction to be conducted. 300μl AL Buffer and 300μl 100% isopropanol were added to the 
homogenate, and the mixture was then transferred to a DNeasy mini spin-column (DNeasy® 
Blood and Tissue kit, Qiagen). DNA extractions were conducted following the manufacturer’s 
protocols. 5l RNase A (invitrogen) was added to the membrane and let sit at RT° for 10 min 
after adding 500l of buffer AW1. All samples were then washed following the manufacturer’s 
protocols and were eluted in a final volume of 200μl buffer AE for 10 min at 70°C.  
 
2.3.3 Quantification and quality check  
RNA/DNA concentrations were assessed by using the Qubit® RNA HS Assay Kit and Qubit® 
dsDNA HS Assay Kit, respectively. Manufacturer’s instructions were followed. All 
RNA/DNA samples were visualized on a 1% agarose gel containing 1:10 GelRed™. 
Approximately 2μl of extracted RNA/DNA were mixed with 3μl of loading buffer (Orange 
G). A 1 kb DNA ladder was loaded along with samples to estimate size and to act as control. 
The gel was run at 110 volts for 45-50 minutes and viewed using a Gel-doc system at 260nm. 
The integrity of RNA was indicated by the presence of clean thicker 28S and thinner 18S 
ribosomal RNA bands (at about 2:1 ratio), and without a DNA band. A thick DNA band 
without any RNA smears was considered good quality DNA.  
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2.3.4 Gene expression analysis 
2.3.4.1 Reverse transcription of RNA 
After Qubit quantification (as described in 2.3.3), RNA samples were diluted to a 
concentration of 100ng/μl, and 8μl of each was used for reverse transcription (RT) reaction. 
DNase treatment was performed prior to RT reactions following the Promega protocol.  After 
DNase treatment, RT was conducted by using the high capacity cDNA reverse transcription 
kit (Applied Biosystems, UK) and the manufacturer’s instructions were followed. For each 
sample, a master mix consisting of: 10x RT buffer (2.0μl), 25x dNTP Mix (0.8μl), 10x RT 
Random Primers (2.0μl), RNasin inhibitor (1.0μl), MultiScribeTM reverse transciptase (1.0μl) 
was added, and the total volume was adjusted to 20.0μl by adding Nuclease-free water. A –
RT (no reverse transcriptase) sample was made: the sample underwent all the procedures 
mentioned above except that nuclease free water was added in place of AMV reverse 
transcriptase. This acts as a negative control to ensure no genomic DNA contamination 
occurred. All samples were then reverse transcribed following the manufacturer’s instructions: 
at 25°C for 10 minutes followed by 37°C for 2 hours, then 85°C for 5 minutes then gradually 
cooled down to 4°C in a G-Storm thermal cycler. The RT products, complementary DNA 
(cDNA), were stored at -20°C.                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 
For cohort 1 cDNA samples, I used 12ul of each sample for dilution 1 in 20, the final volume 
of 240ul of each diluted sample were aliquot into two strip sets. The remaining 8ul of cDNA 
from each sample were pooled together and series dilutions were performed (standard curve 
strips are labelled in red).  For cohort 2 cDNA samples, I used 13ul of each sample for 1 in 20 
dilution, the final 260ul diluted cDNA were aliquot into three strip sets. The remaining 7ul of 
cDNA from each sample were pooled together and stored in one tube (labelled in blue ink as 
pooled cDNA), which can be used to make standard curves when needed.  
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2.3.4.2 Quantitative real-time polymerase chain reaction (qPCR) 
The quantity of mRNA was measured by qPCR. Individual samples of cDNA were diluted 
1:20 in nuclease free water. Samples were run together with a standard curve made by pooling 
cDNA from all the samples and serially diluted in nuclease free water (1:4, 1:8, 1:16, 1:32, 
1:64, 1:128). A –RT control and a non-template control (nuclease free water) were also run at 
the same time to ensure no contamination occurred.  
 
For each assay, 8μl of master mix containing corresponding primers, probe and Roche® probes 
master were loaded into the bottom of a 384 well plate in triplicate (Table 2.1). UPL assays 
were self-designed using the Universal Probe Library™ (UPL) system (Roche Diagnostics 
Ltd., West Sussex, UK). All self-designed UPL assays were intron-spanning assays. 
PrimeTime® qPCR primers and probes were designed by Dr. Jessy Cartier using the Integrated 
DNA Technologies system. ABI assays were bought from Taqman® as primer-probe mix. 
 
After the loading of master mix, 2μl of samples, negative controls and serial dilution of 
standard curve samples were then loaded into the wells in triplicate for each assay. Plates were 
centrifuged for 2 minutes at 1500 revolutions per minute (rpm) and then loaded into the 
LightCycler® 480. The reaction conditions comprised rapid heating to 95°C for 5 minutes for 
denaturation followed by 50 cycles of a denaturation step at 95°C for 10 seconds and annealing 
at 60°C for 30 seconds. The samples were then cooled to 40°C for 30 seconds for completion. 
Acceptable assays had a reaction efficiency value between 1.7-2.1. Data were analysed using 
generalised linear models (JMP statistical software, SAS Institute, Cary, NC, USA). All genes 








Roche Probes Master 5μl 5μl 
Taqman® primer-probe mix - 0.5μl 
Forward primer 0.02μl (100μM) - 
Reverse primer 0.02μl (100μM) - 
Probe 0.1μl (10μM) - 
cDNA 2μl 2μl 
Nuclease free water 2.7μl 2.5μl 
Table 2.1 Recipes for qPCR with self-designed UPL/PrimeTime® primers or 
Taqman® primer-probe mix.                                                                                                          
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2.3.4.3 Rat self-designed UPL primers   




Arc gctgaagcagcagacctga tctgcttttcttcactggtatga 3 74 
Bdnf gcagtcaagtgcctttggag cggcatccaggtaatttttg 65 69 
Calcr gtgctatgaccggattcagc ccaagttcggttgcaatatg 7 67 
Egr1 cgaacaaccctacgagcac gcgccttctcgttattcaga 114 68 
G6pd gcaaacagagtgagcccttc tggctgttgaggtgcttg 75 130 
Gfral cgaaatgatgaattatgcagga caggtctcatcttcacgacact 5 92 
Gnas ttcgcagtggttggaagc accaagaagccgactcacc 21 76 
Gpr101 gaaaggtggccagacagc cagctcaatgtctgccctagt 17 122 
Hprt gaccggttctgtcatgtcg acctggttcatcatcactaatcac 95 61 
Isl1 gcaacccaacgacaaaactaat ccatcatgtctctccggact 83 78 
Ngfr acactgagcgccagttacg catcgaccagggatctcttc 26 70 
Nts tgactctcctggctttcagc gcctccaggactctcacatc 109 70 
Qrfpr cgtgcaacgccttgagat aaggtgctgtagattctctggtg 84 105 
Rspo1 cgacatgaacaaatgcatca ctcctgacacttggtgcaga 5 76 
RBII85 ctgaggatacctgaagtgaaagg caacttcatctgatgttccatactc 6  
Tbp cccaccagcagttcagtagc caattctgggtttgatcattctg 129 75 
Th cggaagctgattgcagaga agcgtgacatatacctccttcc 97 110 
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2.3.4.4 Rat self-designed PrimeTime® primers 
Primer Forward Primer Reverse Primer Probe Position 
ORF2 ccttcatagaagacctcataccaata tgttgtgtctttgtgtggtttag tgaaacagatggagccctaccgaa Universal 
Rat1 ccagctcaaaggaccagtaaa ttatgtgacgggaggtgtttc tggagttctgtaggcttcttgtatgcc Chromosome 1  
Rn1 ctgaaggaaacagaccggataa ggagcagtctcttctggtttc agttctctgcacccaaatcccgt Chromosome 11 
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2.3.4.5 Rat Taqman® primer-probe set  
Primer Accession Number Amplicon (nt) 
Cdkn1c RN00711097_m1 70 
Dio3 RN00568002_s1 63 
Dlk1 RN00587011_m1 74 
GR (Nr3c1) RN01405584_m1 75 
Grb10 RN01401196_m1 101 
Igf2 RN01454518_m1 74 
Snrpn RN00579591_m1 80 
Ube3a RN01409766_m1 65 
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2.3.5 Pyrosequencing 
2.3.5.1 Bisulfite conversion 
After Qubit quantification (as described in 2.3.3), 1μg DNA was made up to 45μl in a 200μl 
PCR tube. All samples were bisulfite converted using an EZ DNA Methylation™ Kit (Zymo 
Research, USA). After the addition of CT conversion reagent, incubation was performed in a 
G-Storm thermal cycler overnight. The incubation conditions comprised rapid heating to 95°C 
for 5 minutes followed by 16 cycles of 95°C for 30 seconds, 50°C for 60 minutes and then 
hold at 4°C. All samples were then washed following the manufacturer’s protocols and the 
final products were eluted in 30l of M-Elution Buffer and stored at -20°C. 
 
2.3.5.2 Polymerase chain reaction (PCR) 
PCR primers were self-designed for the promoter and gene body regions of Arc using the 
PyroMark Assay Design 2.0 software (Qiagen). Igf2-DMR2 and IG-DMR methylation was 
analysed using assays from Dr. Khulan Batbayar. All primers were purchased from Applied 
Biosystems, UK. Primer sequences are listed in 2.3.5.4.  
 
For each assay, 1l of bisulfite converted DNA was used as template in a 20l PCR reaction 
mixture with the addition of primers and AmpliTaq® Gold PCR Master Mix (Applied 
Biosystems). The amount of primers being used was optimized for each assay. A non-template 
control (nuclease free water) was run at the same time to ensure no contamination occurred. 
PCR products were electrophoresed on a 1% agarose/0.5  TBE gel containing 1:10 GelRed™ 
at 110V for 45 minutes. A 100bp DNA ladder was loaded along with samples to estimate size 
and to act as control. Gels were visualized under UV light using a Gel-doc system at 260nm. 
A sharp contrast between the strength of product band and any primer-dimer band was 
considered satisfactory. The optimized PCR program for all assays comprised rapid heating to 
95°C for 10 minutes for denaturation followed by 45 cycles of a denaturation at 95°C for 20 
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seconds, annealing at 56°C for 20 seconds and elongation at 72°C for 20 seconds. The samples 
were then stored at 72°C for 7 minutes for completion.  
 
2.3.5.3 Pyrosequencing 
Pyrosequencing was carried out using the PyroMark Q24 system (Qiagen). 15μl of PCR 
products from 2.3.5.2 was added along with 2μl of streptavidin-coated sepharose beads (GE 
Healthcare Life Sciences, Sweden) and 40μl binding buffer to a 24-well plate. The volume 
was adjusted to 80μl using Milli-Q purified water. Two negative controls (one non-template 
PCR product and one sequencing primer) were loaded on the same plate to ensure no 
contamination occurred. Plates were sealed and agitated for 5 minutes at 14000 rpm. Samples 
were captured using a Pyromark suction device and flushed stepwise following the 
manufacturers’ instructions. The beads were then released into a sequencing primer plate 
prepared by loading 0.3μM sequencing primer in 25μl of annealing buffer. This plate was then 
incubated at 80°C for 2 minutes and cooled down to RT° for 5 minutes to allow the annealing 
of sequencing primers to templates. Appropriate volumes of enzyme, substrate and dNTPs 
(PyroMark Q24 Gold Reagents, Qiagen) were added to the PyroMark Q24 cartridge as 
indicated by the PyroMark Q24 analysis software. The plate was processed by the Pyromark 
Q24 instrument by fitting in the filled cartridge and starting the program, and was then 
analysed by the PyroMark Q24 analysis software.  
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2.3.5.4 Pyrosequencing PCR primers 
Gene Forward Primer Reverse Primer (5’-Biotinylated) Sequencing Primer Amplicon 
length 



























































































Chapter 3 Glucocorticoid programming: 




Fear and anxiety are important emotions. Fear (towards a real, current threat) and anxiety 
(towards an anticipated threat) evoke a stress response in the body, which involves not only 
the immediate physiological and behavioural responses to combat the threats, but also an 
appropriate extinction of the response to maintain internal homeostasis and subsequent 
adaptive behaviour. An inappropriate stress response can express as hypersensitivity to an 
acute stress, and/or a failure to consolidate the memory and make adjustments for future 
behaviour. A number of animal studies have provided evidence that prenatal stress leads to 
physiological and behavioural changes that represent a maladaptive stress response, 
suggesting that prenatal stress may induce susceptibility to stress-related psychopathological 
changes in later life (Koehl et al., 2001).   
 
The physiological activation of the HPA axis system is intimately linked to a stress response. 
Plasma CORT levels are key indicators of HPA axis function. Despite reports that prenatal 
stress leads to elevated basal plasma CORT levels (Green et al., 2011b), the dysfunction of the 
HPA axis induced by prenatal stress seem to predominately involve a failure to attenuate the 
stress response via feedback mechanisms, demonstrated by a heightened or prolonged 
elevation of stress hormones after an acute stress (Weinstock, 1997, Henry et al., 1994, 
Weinstock et al., 1992, Wilson et al., 2013, Maccari et al., 1995, Vallee et al., 1997). There is 
also evidence that prenatal stress affects the time-course of HPA hormone fluctuations after 
repeated exposure to stress (Fride et al., 1986). 
 
Fear and anxiety can also be assessed by behavioural reactions. Several behavioural measures 
are now available allowing for assessment of different aspects of fear and anxiety, including 
unconditioned fear, fear potentiation, fear consolidation and fear extinction. Offspring of 
 50 
stressed dams have been found to show increased fear and anxiety-related behaviour in a 
stressful environment, including increased aversion to the open arms on an elevated plus-maze 
(Wakshlak and Weinstock, 1990, Vallee et al., 1997, Welberg et al., 2001, Estanislau and 
Morato, 2005, Bondi et al., 2008, Poltyrev et al., 1996a), decreased exploration and increased 
defecation in an open field (Poltyrev et al., 1996a, Welberg et al., 2001) and increased 
defensive freezing (Takahashi et al., 1992). In addition, there is evidence that prenatal stress 
leads to impaired habituation and behavioural adaptation after an acute stress. For example, it 
has been reported that prenatally exposed rats exhibit impaired learning and coping strategy 
under stressful situations in a forced swim test (Welberg et al., 2001). Prenatally stressed rats 
have also been reported to demonstrate attenuated fear extinction in a contextual and cued fear 
conditioning test (Green et al., 2011b, Wilson et al., 2013, Markham et al., 2010).  
 
Overall, the current evidence suggests that prenatal exposure to stress affects stress response 





3.1.2 Hypothesis and aim 
I hypothesise that prenatal Dex exposure during the last week of gestation in rats may induce 
programming effects on offspring stress response system, potentially leading to 
hypersensitivity to stress in adult offspring. The aim of this study is to study the prenatal Dex 
effects on relevant aspects of a stress response including HPA axis activity, fear-related 
memory retention and behavioural adaptations.  
 
The content of my current experiments include: a) measuring the basal and stress-induced 
HPA axis activity; b) evaluating unconditioned fear and anxiety-like behaviour on an elevated 
plus maze, open-field and contextual fear conditioning test; and c) evaluating fear conditioning 
and fear extinction in a contextual fear condition test.  
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3.2 Methods 
3.2.1 Animals  
Subjects were adult Wistar rats, bred from 36 adult pairs (Charles River, UK) at the University 
of Edinburgh. Animals were maintained and treated under conditions detailed in 2.2.  
Female rats were housed individually and timed mating was conducted. Following vaginal 
plugging (denoted as E1) pregnant dams were randomly assigned to Dex or vehicle (Con) 
treatment. From E15-E21 inclusive, dams were given a daily subcutaneous injection of either 
Dex (100μg/kg body weight, dissolved in 4% ethanol, 0.9% saline) or an equivalent volume 
of vehicle (4% ethanol, 0.9% saline) (0.5ml/kg).  
 
At birth (postnatal day 1), the offspring were weighed, sexed and litters culled back to eight 
per group, leaving 5 males and 3 females per litter where possible. Litters were then left 
undisturbed until weaning at 3 weeks of age, whereupon female offspring were culled and 
male pups were housed in same groups and left undisturbed until adulthood. 
 
3.2.2 Plasma CORT levels 
Animals (n= 9 per group) were assessed for basal plasma CORT levels in adulthood (aged 
139.61 ± 1.33 S.D. days). Blood samples were obtained by making a small incision near the 
tip of the tail (Fluttert et al., 2000) at two time points, 07.00 and 19.00 h. Rats were directly 
taken from their home cage and sampled with minimal stress.  
 
Another set of animals were used for assessment of stress-induced plasma CORT levels ten 
minutes after the elevated plus-maze test (n=CON:11, DEX:10, aged 72.0 ± 3.95 days). 
Animals were killed by rising concentration of carbon dioxide and then decapitation. Trunk 
blood was collected from the inferior vena cava. All blood samples were collected using EDTA 
coated capillary blood collection tubes (Microvette® CB-300) (Sarstedt) and centrifuged for 
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5 min at 13000 rpm at room temperature. The plasma was then transferred into a new 
Eppendorf™ tube and stored at − 80 °C. Plasma CORT concentrations were analysed by Dr 
Emad Al-Dujaili using enzyme-linked immunosorbent assay (ELISA)(Al-Dujaili et al., 2009).      
  
3.2.3 Elevated plus-maze 
Animals (n=CON:11, DEX:10) were aged 72.0 ± 3.95 S.D. days at testing. The elevated plus-
maze was a cross-shaped platform positioned 80 cm above the floor with two open arms and 
two closed arms (70 cm x 12 cm x 17 cm) on opposing sides of a central area (10 cm x 10 cm). 
At the start of the test a rat was put in the central area facing one of the open arms and allowed 
to explore the maze freely for 5 minutes, during which its behaviour was recorded by a video 
camera mounted above the maze. Following each session the apparatus was wiped clean with 
70% ethanol to remove any olfactory cues. An experimenter blind to treatment groups handled 
the animals and analysed the video recordings. The following parameters were considered: 
number of open arm entries, total number of arm entries and time spent on the open arms.  
 
3.2.4 Open field 
Animals (n= 12 per group) were aged 70.75 ± 4.46 S.D. days at testing. The open field 
apparatus was an illuminated black square box (90cm  90cm  60cm high). The field was 
divided into 9 equal segments. At the start of the test, a rat was placed at the edge of the box, 
in the middle of one of the surrounding walls, and allowed to explore the field freely for 5 
minutes, during which its behaviour was recorded by a video camera mounted above the maze. 
Starting position was counterbalanced between groups. The field was cleaned by 70% ethanol 
to remove any possible olfactory cues between each animal. An experimenter blind to 
treatment groups handled the animals and analysed the video recordings. The parameters of 
interest were determined as: total number of grid crossings, number of entries to the central 
square and time spent in the central square.  
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3.2.5 Contextual fear conditioning 
Animals (n=CON:12, DEX:16) were aged 74.21 ± 5.99 S.D. days at the start of testing, The 
contextual fear conditioning apparatus was a shock chamber (30 × 25 cm, 32 cm high, 16 
shock bars, Coulbourn Instruments, PA, USA). The fear conditioning system was controlled 
via a shocker-scrambler unit automated by the FreezeFrame software (Coulbourn 
Instruments). The protocol consisted of a first day of training, a second day of retention 
(extinction training) and a third day of extinction. On the first day, rats were individually put 
into the chamber and allowed to explore the compartment for 2 min before receiving a 2s, 0.5 
mA foot shock, after which they were left for a further 1 minute to allow for assessment of 
unconditioned freezing behaviour. Approximately 24 hours after the initial exposure, animals 
were returned into the same chamber for 10 min without receiving further foot shock to allow 
for assessment of fear consolidation and retrieval. After another 24 hours animals were again 
put back into the same chamber for another 10 min to allow for assessment of fear extinction. 
Animal behaviour was recorded at all times via a video camera mounted on the roof of the 
chamber. The apparatus was cleaned by 70% ethanol to remove any possible olfactory cues 
between each animal. Animals were coded by letters to blind treatment groups before the start 
of the experiment. An experimenter blind to treatment groups (Anna Moon, University of 
Cardiff) analysed the video recordings. Percentage time of freezing (defined as absence of all 
body movements except breathing) was examined for day 1 over the post-shock 1 min, and 
for day 2 and day 3 in blocks of 2 min over 10 min.   
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3.2.6 Statistical analysis 
Data were analysed using generalised linear models (GLMs, JMP statistical software, SAS 
Institute, Cary, NC, USA). All data were checked for homogeneity of variance and normality 
of distribution. All statistical models investigated the main effect of Group. Litter (nested 
within group) was fitted as random variable to account for the use of more than one animal 
per litter. For contextual fear conditioning, GLMs were used to investigate the effect of Group 
on unconditioned freezing over the 1 min post-shock on day 1. For day 1 and day 2 data, GLMs 
were used to investigate the effect of Group (CON, DEX), Day (Day 1, Day 2) and all two-
way interactions of these terms on percentage of time spent freezing. For day 2 and day 3 data, 
GLMs were used to investigate the effect of Group (CON, DEX), Day (Day 2, Day 3), Block 
(0-2 min, 2-4 min, 4-6 min, 6-8 min, 8-10 min), and all two-, three-way interactions of these 





3.3.1 Body weight 
Prenatal Dex treatment significantly reduced birth weight in both male and female offspring, 
(F1,14.97=14.64, P=0.002) (n=60-83 per sex/group). Female pups were significantly smaller 
than their male counterparts at birth, (F1,253.6=38.36, P<0.0001). Analysis of body weight at 
weaning at three weeks of age (n=27-44 per sex/group) revealed a significant treatment effect 
in male pups (P=0.020), but not in female pups (P=0.160). Female pups were still lighter than 
male pups at weaning, (F1,122.1=19.69, P<0.0001). The reduced body weight in prenatally Dex-
treated male offspring persisted into adulthood, (F1,15.8=6.77, P=0.019) (n=42-44 per group). 






Figure 3.1 Effects of prenatal Dex exposure on offspring body weight 
Prenatal Dex treatment significantly reduced birth weight in both male and female 
offspring (A); at weaning, the reduction in body weight induced by prenatal Dex 
exposure was only seen in male offspring (B); the reduced body weight in prenatally 
Dex-exposed male offspring persisted through adulthood (C). Data are presented as 
mean  S.E.M. * P 0.05 versus control. ** P 0.01 versus control. 
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3.3.2 Plasma CORT levels 
Figure 3.2 shows that animals from both groups demonstrated a typical diurnal pattern of 
baseline CORT concentration changes. There were no significant differences between the two 
experimental groups in either the morning (F1, 5.55=0.12, P=0.738) or evening basal plasma 
CORT levels (F1, 8.34=0.47. P=0.512). Both groups of animals had similar elevation in plasma 
CORT concentrations after exposure to an acute elevated plus-maze stress, (F1, 9.84=0.40, 
P=0.543).  
 
Figure 3.2 Effects of prenatal Dex exposure on basal and stress-induced plasma 
CORT levels in adult offspring  
There were no significant differences between the two experimental groups in either 
basal CORT levels at 7am and 7pm (A), or stress-induced plasma CORT elevation 10 
min following an acute stress (B). Data are presented as mean  S.E.M. n=9-11/group.  
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3.3.3 Elevated plus-maze 
Figure 3.3 illustrates the performance on an elevated plus-maze. Prenatal Dex exposure had 
no effect on number of entries to the open arms, (F1, 8.21=0.61, P=0.458). Both groups of rats 
spent similar amounts of time on the open arms, (F1, 9.81=0.51, P=0.492). There were no 





Figure 3.3 Performance on an elevated plus-maze 
There were no significant differences between the two experimental groups on 
number of open arm entries (A), time spent on open arms (B) or number of total arm 
entries (C). Data are presented as mean  S.E.M. n=10-11/group. 
 61 
3.3.4 Open field 
Figure 3.4 illustrates the performance over a 5 min open field test. There were no significant 
differences between the two experimental groups on time spent in the central square (F1, 
9,95=1.25, P=0.290) or number of entries to the central square (F1, 7.93=2.10, P=0.186). Student 
t-test revealed a significant effect of Group on total grid crossings (P=0.037), such that Dex-
programmed rats had a higher number of grid crossings. However if litter was fitted as a 
random variable by employing the GLM, there was only a trend towards a difference in total 




Figure 3.4 Performance on a 5 min open field test  
Prenatal Dex exposure had no significant effect on total grid crossings (A), time spent 
in the central square (B) or number of entries to the central square (C). Data are 
presented as mean  S.E.M. n=12/group. 
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3.3.5 Contextual fear conditioning 
Unconditioned freezing 
There were no differences between the two groups in percentage of time spent freezing during 
the 1 min immediately after the food shock, (F1 12=0.29, P=0.600). (Figure 3.5A)  
 
Fear conditioning 
Fear conditioning was assessed by comparing the percentage of time animals spent freezing 
during training (day 1) and retention (day 2). There was no main effect of Day (F1, 138=0.77, 
P=0.381) or Group (F1, 15.01=0.39, P=0.543), however there was a significant interaction 
between Group and Day, (F1, 138=5.75, P=0.018). Post Hoc LSMeans Student’s t tests revealed 
that while control rats were able to retain high levels of conditioned freezing behaviour during 
retention, prenatally Dex-exposed rats had significantly reduced freezing behaviour during 
retention compared to training. (Figure 3.5B) 
  
Fear extinction  
Fear extinction was assessed by comparing the percentage of time animals spent freezing 
during retention (day 2) and extinction (day 3). There was a significant effect of Block, (F4 
234=3.20, P=0.014), such that less freezing behaviour was observed during the first block (0-2 
min) compared to the next 2 blocks (2-6min). (Figure 3.5C) There was a main effect of Day 
(F1 234=25.82, P=0.0001) and no main effect of Group (F1 12=0.94, P=0.351), however there 
was a significant interaction between Group and Day, (F1 234=12.27, P=0.0005). Post hoc 
LSMeans Student’s t tests revealed a significant reduction in freezing behaviour during 




Figure 3.5 Performance on a contextual fear conditioning test  
There were no significant differences between the two groups in unconditioned 
freezing (post-FS) (A); prenatal Dex treatment affected the time-course of freezing 
during retention and extinction, such that compared to controls prenatally Dex-
exposed rats failed to develop conditioned freezing, and they again failed to 
demonstrate an elimination of freezing behaviour during extinction (B); there was a 
significant effect of Block during retention and extinction, such that all animals 
demonstrated significantly higher freezing behaviour about the time when they had 
first received the foot shock (at 2min) (P=0.014) (C). Data are presented as mean  
S.E.M. n=12-16/group. * P< 0.05 versus block 1 (C). 
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3.4 Discussion 
The experimental findings of my current study can be summarized as: a) prenatal exposure to 
Dex during the last week of gestation significantly reduced birth weight in offspring; b) 
prenatal Dex treatment had no effect on baseline or stress-induced plasma CORT levels in the 
adult offspring; c) there were no indications of group difference in unconditioned fear and 
anxiety-related behaviour as evaluated on an elevated plus-maze, open field and contextual 
fear conditioning test; d) prenatally Dex-exposed rats exhibited impaired fear conditioning 
during a contextual fear conditioning test and a trend towards increased spontaneous 
locomotor activity in an open field. 
 
The current data confirmed that Dex treatment during the last week of gestation in rats reduces 
birth weight in offspring, in line with previous findings (Welberg et al., 2001, Nyirenda et al., 
1998, Levitt et al., 1996). Increasing evidence suggests that low birth weight is associated with 
increased risks for neuropsychiatric disorders in later life, including autism (Pinto-Martin et 
al., 2011), schizophrenia (Abel et al., 2010) and ADHD (Breslau et al., 1996). Thus, this 
animal model may provide a potential tool to study related human conditions that are 
associated with low birth weight and to investigate the possible mechanisms underpin fetal 
programming of neuropsychiatric disorders.  
  
Previous studies have reported a full ‘catch up’ in body weight in prenatally Dex-exposed rats 
at weaning (Welberg et al., 2001), however in my current study the reduced body weight in 
prenatally Dex-treated male offspring persisted until adulthood. The postnatal catch-up growth 
could be an additional risk for later diseases (Bavdekar et al., 1999, Leon et al., 1996, Law et 
al., 2002, Eriksson et al., 1999), however it is not in itself a necessity for programming effects 
to occur, as persistent behavioural and molecular changes were still evident even without a 
normalization of body weight in adult rats (Welberg et al., 2001).  
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There were no indications of HPA axis programming from my current experiment, as all 
animals exhibited similar levels of basal and stress-induced CORT concentrations. This result 
appears to contrast with some previous studies, in which researchers reported increased basal 
CORT levels (Green et al., 2011b) or heightened CORT secretion 30 min after an acute stress 
exposure in offspring of stressed dams (Wilson et al., 2013). Differences in animal strains 
(Sprague Dawley rats in these two studies) and prenatal treatment (restraint stress in the Green 
study and repeated variable stress in the Wilson study) may partly account for the variable 
results. In fact, experimental findings vary in this field, with some report HPA hypersensitivity 
only in juvenile prenatally stressed rats, which normalizes in adulthood (Takahashi et al., 1992, 
Takahashi and Kalin, 1991), while others report sex-specific programming of the HPA axis 
where the effects are only seen in the female offspring (Weinstock et al., 1992, Szuran et al., 
2000).  
 
There was no evidence of prenatal Dex programming on unconditioned fear and anxiety-
related behaviour from my current study, as evaluated by a) avoidance of anxiogenic locations 
on an elevated plus-maze and open field; b) exploratory behaviour in an open field; and c) 
acute freezing behaviour on a contextual fear conditioning test.   
 
Aversion to the open arms, including reduced entries and less time spent on the open arms, 
has been validated to be specific indicators for an anxious phenotype (Pellow et al., 1985). In 
my current experiment, I found no significant differences between the groups in tendencies to 
avert open arms on an elevated plus-maze. Although contrast to a number of previous studies 
(detailed in 3.1), similar negative findings have been reported by another group (Wilson et al., 
2013). Large variations in animal strain, prenatal stress regimen and offspring age may all 
contribute to a portion of the controversial results. Notably, in one previous study that used a 
same animal model, researchers reported a trend towards lower entries to the open arms in 
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prenatally Dex-treated rats (P=0.05, n=8-10 per group), with no significant differences in 
amount of time spent on open arms (Welberg et al., 2001). There was also a significant 
reduction of total number of arm entries in prenatally Dex-treated rats (P<0.05), which might 
have confounded the analysis of number of open arm entries. In addition, possible differences 
in rearing conditions and the use of different experimental apparatus and the settings (these 
experiments were performed in different animal facilities) may also contribute to the 
discrepancies. For example, there is evidence that environmental noise can confound prenatal 
Dex effects in Wistar rats (O'Regan et al., 2010). To clarify these possibilities, I have replicated 
the current results with two other cohorts of rats in the same and different animal facilities. 
Despite variations in rearing environment and experimental settings, my results from the three 
cohorts were consistent (n=CON:36,  DEX:39 in total, data not shown) with all three 
replications showing a lack of prenatal Dex programming effects on unconditioned elevated 
plus-maze behaviour.  
 
Similar to the open arms on an elevated plus-maze, the centre of an open field represents an 
anxiogenic location, and it has been suggested that the amount of time spent in the centre and 
entries to the centre of an open field are also indicators for anxiety in rats (Vallee et al., 1997). 
My current data on these parallel measurements supported the elevated plus-maze results, 
suggesting no differences in avoidance of anxiogenic locations between the two experimental 
groups.  
 
Reduced exploratory behaviour is another aspect of fear and anxiety-related behaviour, which 
can be assessed by ambulation (total grid crossings) in an open field test. However this 
measurement can sometimes encompass functionally unrelated activities such as locomotion 
(Prut and Belzung, 2003), especially when antagonistic actions of reduced exploration 
(Welberg et al., 2001) and increased spontaneous locomotion (Diaz et al., 1997, Wilson et al., 
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2013) have both been reported following prenatally stress exposure. In some studies, 
horizontal open field activities such as grid crossings are used as indicators of locomotion, 
whereas vertical activities such as rearing and sniffing are used as indicators of exploration 
(Wilson et al., 2013). In other studies, the overall open field behaviour is analysed as 
spontaneous locomotor activity, researchers have however distinguished the first 10 min of 
open field as exploratory period and the next 20 min as habituation period (Diaz et al., 1997). 
In my current experiment there was a tendency towards increased total grid crossings over the 
5 min open field test in prenatally Dex-programmed rats. The current finding is consistent with 
a good number of studies in which offspring of stressed dams exhibit increased locomotor 
activities, especially during the initial 5 min of exposure to the open field (Wilson et al., 2013, 
Vallee et al., 1997, Gue et al., 2004, Markham et al., 2010). In particular, prenatal exposure to 
glucocorticoids has been shown to induce increased spontaneous locomotion in rats (Diaz et 
al., 1997). This is potentially interesting because hyperactivity is a common symptom for 
neuropsychiatric disorders such as ADHD (Grizenko et al., 2008), and one risk of which has 
been associated with prenatal stress.  
 
Fear and anxiety-related behaviour can also be measured by acute unconditioned freezing 
behaviour in a contextual fear conditioning test. Again, there were no differences between the 
groups on percentage of time spent freezing over the 1 min immediately after receiving the 
electrical foot shock. Taken together, the above results suggest there were no effects of 
prenatal Dex exposure on unconditioned fear and anxiety-related behaviour in the adult 
offspring in rats.  
 
In addition, the contextual fear conditioning test also allows for assessment of hippocampus-
dependent acquisition, consolidation, retrieval and extinction of fear-related memory (Rudy et 
al., 2004). Contextual fear conditioning assesses for the ability to associate fear with a related 
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context and to consolidate and retrieve this memory upon re-exposure. Fear extinction assesses 
for the ability to reconsolidate a previously learned memory and adapt to the new experience 
in which the context is no longer predictive of aversive electric foot shock. Interestingly, in 
the current contextual fear conditioning test, prenatally Dex-exposed rats demonstrated altered 
time-course of freezing behaviour during both retention and extinction. Compared to controls, 
prenatally Dex-exposed rats failed to develop conditioned freezing behaviour during retention, 
and as a consequence, they also failed to eliminate the freezing behaviour during extinction. 
Collectively, my current study suggests that prenatal Dex treatment resulted in impaired 
hippocampus-dependent contextual fear recall 24 hours after the initial conditioning in adult 
male offspring. This result is contrary to previous reports, in which researches found no effects 
of prenatal exposure to stress on percentage of time spent freezing during a contextual fear 
recall 24 hours (Markham et al., 2010) and 48 hours (Wilson et al., 2013) after the initial 
conditioning. Discrepancies between studies could be due to variations in animal strains 
(Sprague Dawley rat in these two studies), prenatal stress regimens (repeated variable prenatal 
stress from E14 in these two studies). There are also considerable differences in fear 
conditioning protocols, for example, the Markham study used four tone-shock pairings 
(1.0mA, lasting 1s, 90s apart), the Wilson study used two foot shocks (0.7mA, lasting 1000ms, 
1 min apart), and both studies measured fear retention only for a period of 5 min.   
 
The current data on fear extinction is inconclusive because prenatally Dex-exposed rats failed 
to develop an adequate conditioning in the first place. Extension of conditioning training in 
prenatally Dex-treated animals would enable reliable fear conditioning to investigate any 
possible effect of prenatal Dex treatment on fear extinction. This is potentially interesting 
because previous studies report prenatal exposure to stress leads to impaired contextual 
(Wilson et al., 2013) or cued fear extinction in male rat offspring (Green et al., 2011b, 
Markham et al., 2010).  
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Taken together, the results from my current experiment suggest that prenatal exposure to Dex 
during the last week of gestation in rats had no observable effect on acute stress responses, but 
resulted in impaired hippocampus-related contextual fear conditioning in the adult offspring. 
The current experiment also revealed a trend indicating increased spontaneous locomotor 











Chapter 4 Glucocorticoid programming: 




Several human studies have provided evidence that maternal anxiety and stress during 
pregnancy affect cognitive development of the child, including intellectual, language, 
impulsion and memory abilities (Laplante et al., 2004, Buitelaar et al., 2003, Van den Bergh 
et al., 2005, Buss et al., 2011). In laboratory animals, prenatal exposure to stress has been 
associated with impaired performance on cognitive tasks related to hippocampus and PFC 
function, including contextual or cued fear conditioning and extinction (Markham et al., 2010, 
Green et al., 2011b, Wilson et al., 2013), spatial reference memory (Lemaire et al., 2000, Son 
et al., 2006, Yang et al., 2006, Brabham et al., 2000, Markham et al., 2010) and working 
memory (Markham et al., 2010, Gue et al., 2004).  
  
In the previous chapter, I have demonstrated that prenatal exposure to Dex induced impaired 
hippocampus-related contextual fear conditioning in the adult offspring in rats. I thus wanted 
to investigate further on other aspects of cognitive outcomes induced by prenatal Dex 
treatment, in particular PFC-related cognitive function. This is interesting firstly because PFC 
dysfunctions are key characteristics of a variety of neuropsychiatric disorders such as 
schizophrenia, depression and anxiety disorders (Murphy et al., 1999, Goldman-Rakic, 1994, 
Kuperberg and Heckers, 2000). Secondly, there is evidence that maternal anxiety during 
pregnancy leads to PFC-related cognitive impairments in adolescents (Mennes et al., 2006, 
Van den Bergh et al., 2005).  
 
In this chapter, I aimed to further investigate the impact of prenatal Dex exposure on cognition 
in adult rat offspring by employing a range of behavioural measures, including a) a spatial 
reference memory task with reversal learning; b) a delayed matching to position (DMTP) task; 
and c) an intra-dimensional/extra-dimensional (ID/ED) attentional set-shifting test.  
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The spatial reference memory task has been developed and validated as a robust measure of 
hippocampus-dependent spatial navigation and reference memory (D'Hooge and De Deyn, 
2001). The reversal-learning phase requires the animal to withhold a formerly learned response 
and adapt its behaviour according to changes in stimulus–reward contingencies. The neural 
substrate underlying the reversal learning has been ascribed to the orbital PFC (McAlonan and 
Brown, 2003).  
 
The DMTP task allows for assessment of working memory and behavioural flexibility, both 
of which have been ascribed to the PFC (Kesner, 2000). In humans, working memory involves 
short-term retention of visuo-spatial information and executive function of manipulating this 
information to guide for subsequent responses (Baddeley, 1992). The classic DMTP task is 
carried out in a radial arm maze, where working memory deficits can be characterized by either 
the ‘delay’ component (delay-dependent or delay independent deficits) (Dunnett et al., 1989), 
or the ‘spatial matching’ component (working memory correct and working memory incorrect 
errors) (Bimonte et al., 2000). In the current DMTP task, which was conducted in a Morris 
water maze, only the ‘delay’ part allows for assessment of working memory, whilst the ‘spatial 
matching’ component has been adapted and is more indicative of response inhibition and 
behavioral flexibility. Lesion studies in rats suggest that an efficient performance on the 
DMTP task depends on a coordinated interaction between the hippocampus and PFC (Floresco 
et al., 1997, Seamans et al., 1995). 
 
The ID/ED attentional set-shifting test allows for assessment of attentional shifts between 
different perceptual dimensions. The behavioural flexibility assessed on the above two tasks 
are intra-dimensional shifts, in which the behavioural shifts are made within one particular 
dimension. The ID/ED task assesses not only intra-dimensional shifts (within one perceptual 
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dimension), but also extra-dimensional shifts (between perceptual dimensions). My current 
experiment followed a standard protocol developed by researchers from the University of St. 
Andrews (Birrell and Brown, 2000). It is an analogue to the visual discrimination task, which 
has been decomposed from the original human Wisconsin Card Sorting Test that assesses for 
frontal lobe function (Roberts et al., 1992). The neurological substance that underlying the 
extra-dimensional attentional shifts has been ascribed to medial PFC in rats (Birrell and 
Brown, 2000).  
 
4.1.2 Hypothesis and aim 
I hypothesise that overexposure to glucocorticoids during the last week of gestation may affect 
cognitive function in adult Wistar rat offspring. The aim of this study is to provide a more 
comprehensive picture of the long-term impact of prenatal Dex exposure on offspring 
cognition, particularly those associated with hippocampus and PFC functioning.  
 
The behavioural tasks involved in this chapter include: a) a spatial reference memory task with 
reversal learning; b) a delayed matching to position (DMTP) task; and c) an intra-




Subjects were adult Wistar rats, bred from 20 adult pairs (Charles River, UK) at the University 
of Edinburgh. Animals were maintained and treated under conditions detailed in 2.2.  
 
Female rats were housed individually and timed mating was conducted. Following vaginal 
plugging (denoted as E1) pregnant dams were randomly assigned to Dex or vehicle (Con) 
treatment. From E15-E21 inclusive, dams were given a daily subcutaneous injection of either 
Dex (100μg/kg body weight, dissolved in 4% ethanol, 0.9% saline) or an equivalent volume 
of vehicle (4% ethanol, 0.9% saline) (0.5ml/kg).  
 
At birth (postnatal day 1), the offspring were weighed, sexed and litters culled back to eight 
per group, leaving 5 males and 3 females per litter where possible. Litters were then left 
undisturbed until weaning at 3 weeks of age, whereupon female offspring were culled and 
male pups were housed in same groups and left undisturbed until adulthood. 
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4.2.2 Spatial reference memory with reversal learning 
Animals (n=12 per group) were assessed on the spatial reference memory with reversal 
learning task at age 100.38 ± 6.39 S.D. days at the start of testing. This task was carried out in 
an open-field water maze. The maze was a water tank of 2m in diameter and 0.5m in depth, 
filled with water made opaque by mixing it with 300ml of liquid latex (temperature 25oC  
1oC). An escape platform (12 cm in diameter) was submerged 1.5 cm below the water surface. 
The maze was surrounded by a collection of prominent two- and three-dimensional visual 
cues. Animal behaviour was monitored using a video tracking system via a camera fixed above 
the centre of the maze, and was analysed by a water maze software (Tracker- P. Spooner, 
Edinburgh, UK). For each trial, the latency to reach the platform, path length, and swimming 
speed was measured. Four points of equal spacing along the circumference of the pool were 
signified as starting points: North (N), East (E), South (S) and West (W). Likewise, the 
swimming pool was conceptually divided into four quadrants accordingly, NE, SE, SW and 
NW.  
 
The spatial reference memory with reversal learning task consisted five days of initial training 
and another five days of reversal learning. For each rat, the platform location remained 
constant (either NE or SW quadrant, 60 cm from the wall, counterbalanced between groups) 
throughout the first five days of training, and was moved to the opposite quadrant (SW or NE) 
for the following 5 days of reversal learning. On each day, a rat was given five trials in a row, 
with an inter-trial interval (ITI) of approximately 15s. At the start of each trial the rat was 
carefully lowered into the water, facing one of the four starting points. Starting position was 
counterbalanced between groups. The sequence of the starting positions was randomized, with 
at least one start at N, E, S and W on each day, avoiding repeats for two consecutive trials.  
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The first trial of each day was run as a probe trial. Probe trials used the “Atlantis” platform 
(Spooner et al., 1994), which was pushed down at first to render it unavailable and set to rise 
at 60s by using a computer-controlled electromagnet, and the animal was given a further 30s 
to find it. The percentage of time spent near the two possible platform locations (radius 20.0) 
during the first 60s was analysed. The following trials on each day (trials 2-5) were standard 
trials, during which rats were allowed 120 seconds to find the platform before being ushered 
towards it. Once a rat reached the platform, it was allowed to remain on the platform for 30s 
before being taken off and moved on to the next trial. 
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4.2.3 Delayed matching to position 
Animals were assessed on the DMTP task at age 90.92 ± 12.11 S.D. days at the start of testing. 
The DMTP task was carried out in the same water maze apparatus as detailed in 4.2.2. This 
task comprised seven days of initial training followed by three blocks of delayed tests, each 
of these blocks continued for five days. On each day, the platform location was different, 
randomly selected from one of the 28 possible locations situated in an inner (1m in diameter) 
and outer (1.5m in diameter) ring of the swimming pool (Figure 4.1). For a given rat, the 
platform location remained the same for all the trials on that day. Each rat received four trials 
per day, the starting position for each trial was considered in relevance to the location of the 
platform, designated as far right (FR), far left (FL), near right (NR) and near left (NL). On 
each day, the sequence of starting positions was randomized for the four trials with at least 
one start at each. The sequences of the daily platform locations and relative starting positions 




Figure 4.1 Platform locations in a DMTP task 
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DMTP- training phase 
During the training phase all rats were given four consecutive trials per day for seven days. 
The platform was placed according to the pre-designed location, and submerged 1.5cm below 
the water surface before the trials began. On each trial the rat was allowed 120s to find the 
platform, before being guided towards it. Once the rat climbed on the platform it had 30s to 
remain on the platform. An experimenter would then remove the rat and allow a 15s ITI before 
moving on to the next trial.  
 
DMTP- delay phase 
During the delay phase, the training protocol was the same as before, except that we introduced 
a delay time of 15 seconds, 20 minutes, or 2 hours between the first and the second trial, during 
which time animals were dried and returned to their home cage. The delay phase included 
three blocks, each continued for five days, with two days of break in between. Within each 
block, rats were assigned to one of the three delays in a counterbalanced fashion, and remained 
on that delay for five days. On the last day of each block, the second trial was run as a probe, 
to allow for assessment of working memory. Probe trials used the same “Atlantis” platform, 
as detailed in 4.2.2, during which the percentage of time spent near the most recently trained 
platform location (radius 20.0) was analysed.  
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4.2.4 ID/ED attentional set-shifting 
Animals (n=CON:10, DEX:12) were assessed using the ID/ED test at age 144.00 days ± 10.11 
S.D. days at the start of the test. The apparatus was adapted from a home cage. A fixed plastic 
panel was set to divide one third of the length of the cage into two sections. In each section, a 
ceramic bowl was placed in the middle, which can be filled with digging medium and scented 
with odour. Two removable dividers were set in between the waiting area and the two sections, 
which can be operated by the experimenter to allow or block the rat’s access to each section.  
 
ID/ED habituation: 
Rats were maintained on restricted diet with free access to water during the whole experiment. 
On the night before the experiment, each rat was given a sawdust-filled ceramic bowl with 6 
Honey Nut Loops (Kellogg, Manchester, UK) buried in it. On the next day, each rat was 
individually placed in the waiting area of the apparatus and allowed free access to both 
separated sections. A sawdust-filled digging bowl with one-half of a honey loop buried in it 
was placed in the middle of each section. Both bowls were rebated every 5 min, or after the 
rat had retrieved food from both sides. Baits were buried each time deeper until near the 
bottom. This process was repeated until the rat could reliably dig to retrieve rewards from both 
sides. After this, the rat was exposed to the six pairs of exemplars that would be used during 
the test (3 digging medium pair and 3 odour pair). For each rat, the six pairs of exemplars to 
be used were randomly chosen from a list of fourteen pairings (Table 4.1). Rats were trained 
to dig in any of these exemplars to retrieve treats before carrying on to the next stage. This 
might take up to several days, depending on the individual rat. 
 
ID/ED training: 
Before starting, each rat was accustomed to all the six pairs of exemplars again for another 
time. Afterwards, it was trained on two simple discrimination (SD) tests (all rats were trained 
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on the same training exemplars, which were not used again during testing). A SD test began 
by lifting up the dividers and exposing the rat to the two separated sections. Digging bowls 
were placed in the middle of each section, and were filled with the training pair of digging 
medium or odour-scented sawdust, depending on the perceptual dimension of the SD test 
(digging medium versus odour). On each trial, the correct exemplar remained the same, and 
only the bowl with the correct exemplar was baited with treat. The rat was allowed to explore 
both bowls on the first four trials to learn the correct digging medium or odour. On subsequent 
trials, if the rat started to dig in the wrong bowl, the trial was terminated and an error was 
recorded. The trials continued until the rat had reached a criteria of six consecutive correct 
trials.  
 
ID/ED testing:  
One day after training, rats were tested on a series of seven discriminations (Table 4.2). A SD 
test was the same as described in the training and involved only one perceptual dimension (for 
example, digging medium). For the compound discrimination (CD), a second dimension 
(odour) was added, but the correct and incorrect exemplar was the same as the SD. For intra-
dimensional discrimination (ID), two new pairs of exemplars were introduced, but the relevant 
perceptual dimension was the same as the CD (digging medium). For extra-dimensional 
discrimination (ED), another two new pairs of exemplars were used and the relevant 
dimension was also changed (odour). For each reversal after the CD, ID and ED (Rev1, Rev2 
and Rev3), the exemplars being used and the relevant dimensions remained the same, but the 
correct and incorrect exemplars were reversed. The criteria were the same as in the training, 




 Odour Medium 
Training pairing  Oregano Mint Polystyrene Confetti 
Pairing 1 Ginger Cinnamon Coarse Hay Small Hay 
Pairing 2 Paprika Sage Sand Grit 
Pairing 3 Cloves Turmeric Coarse wood Fine wood 
Pairing 4 Coriander Dill Cigarette filters Wool 
Pairing 5 Tarragon Fenugreek Paper  Cotton wool 
Pairing 6 Marjoram  Cumin Coarse tea Fine tea 
Pairing 7 Carraway seeds Thyme  Hama Beads Baken Beans 
 









SD O1/O2 Non-dissociable 
CD O1/O2 M1/M2 
CD Rev O2/O1 M1/M2 
ID O3/O4 M3/M4 
ID Rev O4/O3 M3/M4 
ED M5/M6 O5/O6 
ED Rev M6/M5 O5/O6 
 
Table 4.2 Sequence of discriminations in an ID/ED task 
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4.2.5 Statistical analysis 
Data were analysed using GLMs (JMP statistical software, SAS Institute, Cary, NC, USA), 
followed by post hoc LSMeans Student’s t tests, where appropriate. All data were checked for 
homogeneity of variance and normality of distribution. For all statistical model, animal 
identity (nested within litter and group) and litter (nested within group) were fitted as random 
variables to account for repeated measurements and the use of more than one animal per litter.  
 
For the spatial reference memory with reversal learning task, GLMs were used to investigate 
the effects of Group, Trial, Day, and all two-, three-way interactions of these terms on latency 
to platform, path length, percentage of time near the wall and average swimming speed for all 
the standard trials (trials 2-5). For probe trials (trial 1), GLMs were used to investigate the 
effects of Group, Day and two-way interactions of these terms on percentage of time near the 
initial training platform.  
 
For the DMTP task, data were analysed separately. For the training phase, GLMs were used 
to investigate the effect of Group, Trial, Day, and all two-, three-way interactions of these 
terms on latency to platform, path length, percentage of time near the wall and average 
swimming speed for all the trials (trial 1-4). For the delay phase, GLMs were used to 
investigate the effect of Group, Delay, Trial, and all two-, three-way interactions of these terms 
on latency to platform, path length, percentage of time near the wall and average swimming 
speed on all the trials from the first four days of each block. GLMs were also employed to 
investigate the effect of Group, Delay and two-way interactions of these terms on saved latency 
time from trial 2 to trial 1 on the same datasheet. For probe trials (the second trial on the last 
day of each block), GLMs were used to investigate the effect of Group, Delay, and two-way 
interactions of these terms on percentage of time spent near the most recently trained platform 
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location divided by the total amount of time spent near the other seven related locations, sitting 
at the vertices of an octagon.  
 
For the ID/ED task, GLMs were used to investigate the effect of Group, Discrimination (SD, 
CD, CD Rev, ID, ID Rev, ED, ED Rev) and two-way interactions of these terms on number 
of trials to criteria. Reversal learning was assessed by animal performance on reversals (CD 
Rev, ID Rev, ED Rev) versus initial acquisitions (SD, CD, ID, ED). GLMs were used to 
investigate the effect of Group, Phase (initial, reversal) and two-way interactions of these 
terms on number of trials to criteria. For the ID and ED data only, GLMs were used to 
investigate the effect of Group, Discrimination (ID, ED), Sequence (odour to medium, medium 
to odour), and all two-, three-way interactions of these terms on number of trials to criteria. 




4.3.1 Spatial reference memory with reversal learning 
Latency to platform 
Figure 4.2 demonstrates the latency to platform over ten days of the spatial reference memory 
with reversal learning task. There was a significant effect of Day, (F9, 917=62.27, P<0.0001). 
There was no main effect of Group (F1, 3.676=1.60, P=0.281), however there was a significant 
interaction between Group and Day, (F9, 917=2.40, P=0.011). Post hoc LSMeans Student’s t 
tests revealed that prenatally Dex-exposed animals were significantly slower than controls in 
finding the platform on the first day of training (P<0.05). In addition, on the first day of 
reversal, there was a tendency that control animals took a longer time to learn the new platform 
location (P=0.05 by Student’s t-test).  
 
Probe trials 
Figure 4.3 demonstrates the percentage of time spent near the initial training platform (radius 
20.0) on probe trials. There was a significant effect of Day, (F9, 189=11.35, P<0.0001), such 
that all animals spent increasingly more time around the training platform as days progressed, 
reaching a stable level by day 5. On day 7, after the reversal, the time they spent near the initial 
training platform dropped to a baseline level, which was not different from that seen on the 
first day of training. Both groups of animals performed equally on probe trials, as there was 
no main effect of Group (F1, 4.722=0.03, P=0.863) and no interaction between Group and Day 
(F9, 189=0.72, P=0.690).  
 
Locomotor activity 
There were no significant differences between the groups in average swimming speed during 
the whole experimental period, (F1, 4.50=0.71, F=0.443). Likewise, no significant difference 
was found in percentage of time spent near the wall, (F1, 6.77=0.44, P=0.530). 
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Figure 4.2 Performance on a spatial reference memory with reversal learning 
There was a significant interaction between Group and Day in latency time to 
platform (P=0.011) (A); both groups of animals showed similar preference for the 
training platform location when memory was probed 24 hours after the last trial (B). 
Data are presented as mean  S.E.M. n=12/group. 
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4.3.2 Delayed matching to position 
Latency to platform in the DMTP training phase 
Figure 4.3 illustrates the latency to platform during the training phase. Statistical analysis 
revealed a significant effect of Day (F6, 594=31.86, P<0.0001), such that all animals improved 
their performance as days progressed, reaching a steady level by day 4. There was also a 
significant effect of Trial (F3, 594=31.35, P<0.0001), as animals took significantly longer time 
to find the platform on the first trial compared to the other three within a day. Moreover, there 
was a significant effect of Group (F1, 7.69=8.16, P=0.022), with Dex animals taking significantly 
less time than controls to find the platform (Figure 4.3B). There were no interactions between 
Group and Day, (F6, 594=0.68, P=0.666). An identical pattern of performance was seen when 
path length was used as the dependent variable. (Data not shown) 
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Figure 4.3 Performance during the training phase of a DMTP task 
There was a significant effect of Group (P=0.022), with Dex animals taking 
significantly less time than controls to find the platform (B). Data are presented as 
mean  S.E.M. n=12/group. * P< 0.05 versus control. 
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Latency to platform in the DMTP delay phase 
There was a significant effect of Trial, (F3, 1034=36.75, P<0.0001). Post hoc analysis showed 
that animals had a shorter latency on the second trial compared to the first, with further 
improvements on the last trial. There was no main effect of Delay (F2, 1034=0.36, P=0.70), 
however there was a significant interaction between Delay and Trial, (F6, 1034=2.38, P=0.028). 
Post hoc LSMeans Student’s t tests showed that animals were significantly faster on the second 
trial in the 15s and 2 h delay, whereas in the 20 min delay, animals only showed a significant 
improvement on the forth trial compared to the first one. There were no three way-interactions 
between Group, Delay and Trial, (F6, 1034=1.39, P=0.217). Notably, there was a significant 
effect of Group (F1, 9.592=5.58, P=0.041), with Dex animals taking significantly less time to 
find the platform than controls. (Figure 4.4A-D)  
 
Saved time from trial 2 to trial 1 in the DMTP delay phase 
There was no significant effect of Group in saved time from the second trial to the first during 
the delay phase, (F1, 8.371=0.33, P=0.58). There was no significant effect of Delay (F1, 258=0.76, 
P=0.38) and no interaction between Group and Delay, (F1, 258=1.53, P=0.217). (Figure 4.4E) 
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Figure 4.4 Performance during the delay phase of a DMTP task  
There was a main effect of Group, such that Dex animals were significantly faster than 
controls to find the platform (P=0.041) (D). There was no main effect of Delay or any 
interactions between Group and Delay. However there was a significant interaction 
between Delay and Trial, such that all animals had significantly shortened latencies 
on the second trial during the 15s (A) and 2 h delay (C), whereas there was only a 
significant improvement on the forth trial during the 20 min delay (B). Saved time 
from trial 2 to trial 1 was equal between different groups and delays (E). Data are 
presented as mean  S.E.M. n=12/group. * P< 0.05 versus trial 1 (A-C); * P< 0.05 
versus control (D). 
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Probe trials 
There were no significant differences between the two experimental groups in terms of total 
amount of time spent around all the 28 platform locations (F1, 8.52=1.61, P=0.239), suggesting 
there were no deficits in learning the possible platform locations between the two groups.   
 
Probe trial data was analysed as the relative time spent near the most recently trained platform 
compared to the total amount of time spent near the other seven related locations, sitting at the 
vertices of an octagon. There was no significant effect of Group (F1, 8.332=1.65, P=0.23), no 
significant effect of Delay (F2, 44=0.59, P=0.558) and no interaction between Group and Delay, 
(F2,44=0.48, P=0.621). The average probability of swimming around the training platform 
location was 0.245  0.140 S.D. for all animals, above the chance level, which was 0.125 for 
our analysis.  (Figure 4.5) 
 
Locomotor activity 
There were no significant differences between the groups in average swimming speed (F1, 
8.01=0.68, F=0.432) or amount of time spent near the wall during the whole experiment period, 
(F1, 7.53=2.34, P=0.167).  
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Figure 4.5 Performance on probe trials of a DMTP task  
Both groups of animals showed similar preferentiality for the most recently trained 
platform location after any of a 15s, 20 min or 2 h delay. Data are presented as mean 




4.3.3 ID/ED attentional set-shifting 
Discrimination learning 
Figure 4.6 shows the number of trials to criteria on each of the discriminations. On average a 
rat took 10 trials to learn the SD. All animals demonstrated equal performance on each of the 
discriminations, as there was no significant effect of Group (F1,10.55=3.2, P=0.102) or any 
interaction between Group and Discrimination, (F6,126.1=0.71, P=0.639).   
 
Reversal learning 
There was a significant effect of Phase (F1,136.2=14.13, P=0.0003), such that all rats required 
significantly more trials to learn the reversal compared to initial acquisition. There was no 
effect of Group on reversal learning, (F1,10.85=3.15, P=0.104).  
 
ID/ED shifts 
The sequence of perceptual dimensions had no effect on performance, (F1,32.4=0.03, P=0.859). 
All animals demonstrated equal performance on ID and ED shifts, as there was no main effect 
of Group (F1,11.85=0.002, P=0.969), no main effect of Discrimination (ID, ED), (F1,26.69=0.80, 




Figure 4.6 Performance on an ID/ED attentional set-shifting task  
Both groups of animals had equal performance on any of the seven discriminations. 
Data are presented as mean  S.E.M. n=10-12/group.  
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4.4 Discussion 
The experimental findings of my current study can be summarized as: a) prenatal Dex 
treatment during the last week of gestation in rats induced a transient deficit in spatial short-
term memory in the adult offspring; b) prenatal exposure to Dex had no effect on spatial 
reference memory and working memory in the adult offspring; c) prenatally Dex-exposed rats 
had shorter latencies in the reversal learning and DMTP tasks; d) there were no effect of 
prenatal Dex exposure on ID/ED attentional set-shifting.  
 
From the spatial reference memory task, prenatally Dex-treated rats demonstrated a transient 
deficit in locating the hidden platform on the first day of initial training. However, they were 
able to improve their performance and catch up with controls on the following day, indicating 
that their spatial reference memory was not affected. This was further supported by probe trial 
measures, in which all animals showed equal performance in their preferentiality to swim near 
the training platform on the second day of training. The current result does not support some 
previous studies in which offspring of stressed dams were found to have deficits in spatial 
reference memory (discussed in 4.1), however the current study used a different rat strain from 
all these studies which might account for the apparent discrepancies. In addition, experimental 
findings have been mixed in this field, with differences between studies potentially arising due 
to variations in animal strains, regimens of prenatal stress, ages and sexes of the offspring 
(Markham et al., 2010, Szuran et al., 2000). There is also evidence that task-related intensity 
of stress such as the water temperature may affect water maze findings, for example prenatal 
stress induced impairments in water maze performance are only observable when tested under 
cold water but not warm water (Szuran et al., 1994, Szuran et al., 2000).   
 
My results also revealed a tendency that Dex-programmed animals were faster in locating the 
new platform position on the first day of reversal. This result indicates that prenatally Dex-
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exposed animals are faster in responding to the immediate shift in experimental rules. 
However, this effect was only short-lasting and both groups of animals performed equally on 
the probe trial 24 hours after their first exposure to the new platform location. In addition, the 
percentage of time they spent near the old platform location was substantially reduced and was 
equivalent to chance searching, suggesting that both groups of animals were able to inhibit the 
previously rewarded response and adapt to the newly acquired information on the second day 
of reversal. Taken together, these results suggest that prenatal Dex treatment had no sustained 
effect on hippocampus-related spatial reference memory, but induced a transient deficit in 
processing short-term spatial memory and a tendency towards early facilitation of reversal 
learning in the adult male offspring.  
 
The results on reversal learning indicated possible alterations in PFC-associated cognitive 
function (Debruin et al., 1994, Lacroix et al., 2002). I therefore carried out a second water 
maze test, the DMTP task, which assesses for higher cognitive function preferentially related 
to PFC, including working memory and behavioural flexibility. The working memory is 
characterized by delay-dependent or delay-independent impairments. Working memory 
deficits are delay-dependent, which are more explicit at longer delays when the load of 
working memory increases. By contrast, delay-independent deficits indicate deficits not 
specifically related to working memory, including sensorimotor function, motivation and the 
general procession of the procedural rules of the task (Dunnett et al., 1990, Dunnett et al., 
1989). The behavioural flexibility assessed in the DMTP task is similar to that involved in the 
reversal learning, including shifts in responses to stimulus-related spatial information. 
However the reversal learning involves only one rule-switch at the reversal, whereas the 
DMTP task intensified the shifts in task-requirement to involve daily changes of platform 
locations. Thus, if there were any potential group differences in behavioural flexibility, as 
indicated by the reversal learning, it might become more explicit in the DMTP task.   
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Interestingly, my current results revealed a significant treatment effect on DMTP performance, 
with prenatally Dex-programmed rats having shorter latencies to platform over the whole 
experiment. The faster acquisition in prenatally Dex-exposed rats indicates increased 
flexibility in responding to changes in environmental circumstances. This result is consistent 
with the reversal learning, and the behavioural difference did become more explicit in the 
DMTP task as the task requirement intensified to involve much more frequent behavioural 
shifts.  
 
However, my current results revealed no main effect of Delay or any interaction between 
Group and Delay in latency time to platform and saved time from trial 2 to trail 1, suggesting 
that the difference in performance were caused by delay-independent deficits, rather than 
delay-dependent deficits. As discussed above, this result indicates that working memory may 
not be affected by prenatal Dex-treatment, which was further supported by their equivalent 
performance on probe trials after any time of a delay. Instead, the current results suggest that 
the increased behavioural flexibility in prenatally Dex-exposed rats may involve non-
mnemonic processes interfering with learning and executive function, including sensorimotor 
function, motivation, attention, impulsivity and response inhibition.  
 
Since all animals were able to use spatial visual cues to navigate around the water maze, any 
global deficits in visual perception or swimming ability can be excluded. There were no group 
differences in locomotion, as measured by swimming speed. Likewise, there were no deficits 
in their primary motivation to escape from the water maze, as all animals were driven to find 
the platform irrespective of how long it takes.  
 
A possible contribution of impaired attention and impulsivity cannot be excluded, such that 
prenatally Dex-exposed rats may respond faster due to a lack of sustained attention or 
endogenous response inhibition, resulting in an increase in spontaneous response, thereby 
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yielding a 'facilitation' during the DMTP task. There is evidence from previous study that a 
lack of response inhibition leads to an increase in nondiscriminated response, and thus results 
in ‘false facilitation’ during reversal of a spatial discrimination task (Salazar et al., 2004). In 
my current DMTP task, if the faster responses of Dex-programmed animals were driven by 
increased impulsivity and were nondiscriminated, we might observe less response latency and 
more spontaneous errors, which cannot be tested under the current DMTP protocol, and 
additional experiments would be required to elucidate this further.  
 
A less perseveration to the previous rewarded response could also account for the increased 
behavioural flexibility in prenatally Dex-exposed animals. However the current DMTP task 
do not give direct evidence for possible differences in perseveration tendencies and additional 
experiment might be required to investigate this issue further. Overall the current evidence 
suggests that prenatally Dex-treated animals are more flexible in shifting their responses to 
changes in stimulus-reward contingencies, potentially linked to increased cognitive flexibility 
and responsive adaptability.  
 
The behavioural flexibility assessed on the above two water maze tasks involves only intra-
dimensional shifts in response to changes in task requirements. I took this further by carrying 
out a next ID/ED attentional set-shifting task on another set of animals, which assesses both 
intra-dimensional (Revs, ID) and extra-dimensional (ED) behavioural flexibility within and 
between perceptual dimensions. My current results suggest that there was no overall group 
difference on ID/ED performance, thus prenatal Dex exposure had no effect on behavioural 
flexibility in terms of reversing a stimulus-reward association within a particular perceptual 
dimension, as well as attentional set-shifting between perceptual dimensions. The sequence of 
shifting (odour to medium versus medium to odour) had no effect on performance, thus there 
were no differences regarding the ease in making the two kinds of shifts. Previous studies 
report learning is faster within the same dimension (ID) compared to ED in Lister Hooded rats 
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(Birrell and Brown, 2000) and mice (Garner et al., 2006). However, in my current experiment 
all animals including controls performed equally well on ID and ED shifts, suggesting that the 
ID/ED task may not be a sensitive measure for cognitive set-shifting in Wistar rats.  
 
Taken together, my current results suggest that prenatal exposure to Dex affected cognition in 
adult male offspring in rats. There was little evidence that prenatal Dex treatment had any 
effect on mnemonic processes, except for a transient deficit in processing spatial short-term 
memory. Prenatal Dex-treatment had no effect on attentional set-shifting within and between 
perceptual dimensions, however it facilitated behavioural flexibility in responding to changes 
in stimulus-reward associations within the water maze tasks, potentially associated with 









Chapter 5 Mechanisms of programming: 




Human and animal studies suggest that prenatal stress influences the development of the brain 
and the organization of behaviour, characterized by a number of neuroendocrine, behavioural 
and neurobiological changes in the offspring (detailed in 1.1.2). It has been hypothesized that 
the aversive effect of prenatal stress on brain structure and function may be partly mediated 
by altered gene expression in the brain (discussed in 1.1.2 and 1.4.3.1).  
 
In previous chapters, I have reported that prenatal administration of Dex during the last week 
of gestation in rats had no observable effect on HPA axis function and unconditioned fear and 
anxiety-like behaviour in the adult male offspring; however, prenatally Dex-exposed rats 
demonstrated different performance in a contextual fear conditioning test and water maze 
tasks, suggesting altered cognition associated with hippocampus and PFC function. The 
molecular basis underlying these behavioural phenotypes is however not very well understood.  
 
In this chapter I aimed to find out if the long-term effects of prenatal Dex treatment on 
offspring behaviour are correlated with altered gene expression in the brain. Based on my 
current behavioural findings, I am prompted to select candidate genes that are related to 
behaviour strategies and memory function. Three candidate genes were chosen from literature 
review, including glucocorticoids receptors (GR and MR) and brain-derived neurotrophic 
factor (Bdnf). One candidate gene was chosen from the result of a previous Affymetrix 






Glucocorticoids receptors  
The stress hormones act via two receptor types in the brain: the low affinity glucocorticoid 
receptor (GR) and the high affinity mineralocorticoid receptor (MR). Both receptors act as 
transcription factors and regulate different aspects of fear, anxiety and cognitive behaviour 
(Brinks et al., 2009, de Kloet et al., 1999). For example, it has been suggested MR mediates 
the regulation of basal CORT levels during circadian rhythm, whereas GR occupy is involved 
in the negative feedback of a hormonal stress response. In terms of behavioural functions, 
brain MR is thought to mediate acute fear-related behaviour and fear extinction, whereas GR-
occupation is thought to facilitate fear potentiation and consolidation of fear-related memory 
(Korte, 2001, Brinks et al., 2009). In addition, brain MR and GR are involved in different 
aspects of spatial learning, such that MR is necessary for response selection and behavioural 
strategy, whereas GR is involved in consolidation of acquired information (Oitzl and de Kloet, 
1992, Berger et al., 2006).  
 
Bdnf 
BDNF is a member of the neurotrophin family, and is expressed in the brain at different 
developmental stages (Chao, 2003). In addition to its involvement in neurodevelopment, 
BDNF signalling is critical for synaptic plasticity in adults and plays an important role in long-
term potentiation (LTP) in the hippocampus (Leal et al., 2014). There is evidence that prenatal 
stress in rats leads to dysregulation of corticostriatal Bdnf expression associated with 
permanent alterations in brain function (Fumagalli et al., 2004). In addition, BDNF has been 
implicated in a range of neuropsychiatric disorders (Green et al., 2011a, Rakofsky et al., 2012, 






Egr1 is selected from the Affymetrix microarray result from a previous study of our group. 
Total RNA was extracted from the adult male prefrontal cortex of the prenatal Dex treatment 
rat model and 8 samples of good quality total RNA samples (n=CON:4; DEX:4) were selected 
for Affymetrix microarray, with analysis taken place at the Wellcome Trust Clinical Research 
Facility in Edinburgh. According to the microarray, Egr1 was up-regulated in the prefrontal 
cortex of prenatally Dex-treated rats with a fold change of 1.1767, P=0.0176. Egr1 is one of 
the immediate early genes (IEGs) that act by regulating the expression of downstream genes 
in response to neuronal activity (Sukhatme et al., 1988). It has been suggested that the 
expression of IEGs including Egr1 plays a role in synaptic plasticity required for memory 
formation and consolidation processes (Guzowski et al., 2001).  
 
In the context of the current study, these four genes represent important candidates for 
understanding the molecular basis of the behavioural phenotypes induced by prenatal Dex 
administration. I therefore investigated the mRNA expression of these four candidate genes 
by qPCR in dissected brain regions of the prenatal Dex exposure rat model.  
 
In addition to this, our group also carried out a genome-wide next generation RNA-sequencing 
(RNA-Seq) experiment to provide a complete and unbiased picture of the transcriptome of the 
adult PFC after prenatal Dex treatment. Validation of the RNA-Seq results by qPCR revealed 
a prenatal Dex treatment effect to increase the mRNA expression of activity-regulated 
cytoskeletal-associated protein (Arc, also termed Arg3.1) in the adult PFC (fold change 1.70, 
P<0.01). Arc is another IEG (Lyford et al., 1995) together with Egr1 that have been implicated 
in postsynaptic plasticity and memory formation (Korb and Finkbeiner, 2011). In rodents, 
Arc is constantly expressed at low levels under basal conditions and its expression can be 
further induced by neural activities in response to learning (Montag-Sallaz and Montag, 2003). 
ARC protein plays a critical role in LTP and memory consolidation in rats (Guzowski et al., 
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2001). There is evidence that Arc expression is regulated by DNA methylation (Dyrvig et al., 
2012). In the current study, I also aimed at investigating the possible role of DNA methylation 
in mediating the prenatal Dex exposure effects on Arc transcription.  
 
5.1.2 Hypothesis and aim 
I hypothesise that the prenatal gluccocorticoid exposure effects on brain function and 
behaviour may in part be mediated by altered gene expression in the brain. The aim of this 
study is to explore possible molecular mechanisms underlying the prenatal glucocorticoid 
effects on behaviour.  
 
In this chapter I will study the mRNA expression of four candidate genes that are known to be 
involved in behaviour and memory function in the brain of prenatal Dex exposure rat model. 
I will also study the effects of prenatal Dex exposure on the transcriptome of the adult PFC by 




30 female Wistar rats were housed individually and time mated with a stud Wistar male. The 
presence of a vaginal plug was checked daily in the morning. Following vaginal plugging 
(denoted as E1) pregnant dams were randomly assigned to Dex or vehicle (Con) treatment. 
From E15-E21 inclusive, dams were given a daily subcutaneous injection of either Dex 
(100μg/kg body weight) or an equivalent volume of vehicle (4% ethanol, 0.9% saline) 
(0.5ml/kg).  
 
At E20, 12 pregnant females (n=6,6) were killed by carbon dioxide asphyxiation. The fetuses 
were isolated from the uterus and killed by decapitation. Fetal heads were snap frozen on dry 
ice and stored at -80°C. A limb of the fetus was also taken to enable later genotyping for 
determination of sex, since this can be difficult to determine prenatally.  
 
The rest of the pregnant females were allowed to deliver litters normally and after littering 
down (postnatal day 1), pups were weighed, sexed and litters culled back to eight per group.  
Litters were reared by their biological mother until three weeks of age, whereupon female 
offspring were culled and male pups were housed with animals from same treatment group 
and left undisturbed until adulthood, at which point they were sacrificed (n=CON:15, DEX:17, 
aged 88.88  1.88 S.D. days) and the PFC, hippocampus, hypothalamus and cerebellum were 
collected. Each anatomical specimen was immediately frozen and stored at −80°C until use.  
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5.2.2 Sex genotyping for E20 samples 
DNA was extracted from E20 fetal limb using DNeasy® Blood and Tissue kit (Qiagen) and 
followed by PCR for the SRY gene which lies on the Y chromosome to allow for identification 
of male fetuses by gel electrophoresis.   
 
DNA samples were diluted to 1:10 in nuclease free water. Samples were run together with a 
positive control (SRY positive male control), a negative control (SRY negative female control) 
and a non-template control (nuclease free water) to allow identification of male-specific 
chromosome and to ensure no contamination occurred. Primer mix (2μM) was made from 
stock solutions (100μM) with 10μl forward primer (actgttcaagcagtcagccg) and 10μl reverse 
primer (ctccatgaacttggggtc) in 480μl nuclease free water. The PCR reaction conditions 
comprised rapid heating to 95°C for 10 minutes for denaturation followed by 40 cycles of a 
denaturation step at 95°C for 20 seconds, annealing at 58°C for 20 seconds, and elongation at 
72°C for 20 second. The samples were then cooled to 72°C for 7 minutes for completion in a 





Master Mix 10μl 
Solution Q 2μl 
Primer Mix (2μM) 2μl 
DNA (1:10) 1μl 
Nuclease free water 5μl 
 
Table 5.1 PCR recipe for sex genotyping  
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5.2.3 Quantitative real-time PCR 
The whole brains from male E20 embryos were removed from the skull and the frontal lobes 
were used for simultaneous RNA/DNA extraction (as described in 2.3.2). For the adult brain 
tissues, gene expression was examined in dissected brain regions. Right dorsal PFC was used 
for simultaneous RNA/DNA extraction (as described in 2.3.2), and right hippocampus was 
used for total RNA extraction following the RNeasy® mini kit (Qiagen) protocol.  
 
The amount of total RNA was determined using the Qubit® RNA HS Assay Kit (Invitrogen). 
800ng of total RNA (n=CON:10, DEX:8 for E20 frontal lobe; n=CON:9, DEX:10 for adult 
PFC; n=CON:10, DEX:10 for adult hippocampus) was treated with DNase (Promega) and 
then reverse transcribed using the High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems) to produce cDNA. qPCR was performed to examine gene expression by 
TaqMan™ (Applied Biosystems) or UPL (Roche) assays with the addition of 
LightCycler® 480 Probes Master (Roche). Expression of genes was normalized to 
hypoxanthine-guanine phosophoribosyltransferase (Hprt) for adult hippocampus samples, and 
to the average of the three housekeeping genes, Hprt, glucose-6-phosphate dehydrogenase 
deficiency (G6pd) and TATA box binding protein (Tbp) for the E20 and adult PFC samples. 
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5.2.4 Next generation RNA sequencing  
As described in 5.2.3, total RNA was extracted from right dorsal PFC samples (n=CON:9, 
DEX:10) according to the simultaneous RNA/DNA extraction protocol detailed in 2.3.2. A 
RNeasy® plus mini kit was used (Qiagen) instead of a RNeasy® mini kit (Qiagen) and 
manufacturer’s protocols followed. Final product was eluted in a final volume of 30μl RNase-
free water. Total RNA quality was assessed by gel electrophoresis for purity and also on an 
Agilent Bioanalyser (Agilent Technologies) for integrity. The presence of a clean thicker 28S 
and a thinner 18S ribosomal RNA bands (at about 2:1 ratio) without a DNA band on the gel, 
and an RNA Integrity Number (RIN) number above 9.0 on Agilent Bioanalyser was 
considered satisfactory.  
 
8 samples of best quality (n=CON:4, DEX:4) were selected for next generation RNA-Seq. 
After quantification of RNA concentrations by using the Qubit® RNA HS Assay Kit, 1μg of 
total RNA (100ng/ul) was prepared for each sample. Samples were then transported on dry ice 
to Holland where the next generation RNA-Seq was performed by BaseClear (Leiden) and 
data analysis was undertaken by the MRC Computational Genomics Analysis and Training 
(CGAT) facility (MRC Functional Genomics Unit at the University of Oxford).  
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5.2.5 DNA methylation analysis  
Bisulfite-treated DNA samples from E20 frontal lobe (n=CON:10, DEX:10) and adult PFC 
(n=CON:8, DEX:9) were amplified using self-designed primers that targeted either the CpG-
rich region within the Arc promoter or intragenic regions of the Arc gene. Schematic diagrams 
of the examined regions are demonstrated in Figure 5.1.  
 
1l of bisulfite converted DNA was used as template in a 20l PCR reaction mixture with the 
addition of primers and master mix (Table 5.2). The PCR program comprised rapid heating to 
95°C for 10 minutes for denaturation followed by 45 cycles of a denaturation step at 95°C for 
20 seconds, annealing at 56°C for 20 seconds and elongation at 72°C for 20seconds. The 
samples were then stored at 72°C for 7 minutes for completion. Methylation of DNA was 





AmpliTaq Golden Master Mix 10μl 
Primer Mix (2μM) 4μl 
DNA  1μl 
Nuclease free water 5μl 
 




Figure 5.1 Schematic diagram of the examined regions of Arc  
The promoter region is represented in lower-case and the intragenic region is 
represented in upper-case. The start codon ATG (underlined in bold) indicates the 
start of the coding DNA sequence (CDS). The sequences being analysed are shaded in 




5.2.6 Statistical analysis 
Data were analysed using GLMs (JMP statistical software, SAS Institute, Cary, NC, USA). 
All data were checked for homogeneity of variance and normality of distribution. All statistical 
models investigated the main effect of Group. Litter (nested within group) was fitted as 
random variable to account for the use of more than one animal per litter. Data were presented 




5.3.1 Candidate gene expression in the brain 
Figure 5.2 shows the expression of candidate genes in the E20 frontal lobe (A), adult PFC (B) 
and hippocampus (C). The expression of Egr1 was significantly decreased in the E20 frontal 
lobe of Dex-treated embryos, (F1,8.19=10.39, P=0.012). In the adult brain, there was an effect 
of prenatal Dex-exposure to increase the expression of Egr1 in the PFC (F1,11.15=8.26, 
P=0.015), and a trend towards an increased expression of Egr1 in the hippocampus of 
prenatally Dex-exposed rats, (F1,14.51=4.18, P=0.060). There was no effect of prenatal Dex-
exposure on Bdnf expression in the brain. There were no significant differences between the 
groups in GR expression in the E20 frontal lobe and adult PFC, whereas in the adult 
hippocampus there was an effect of prenatal Dex treatment to increase the expression of GR, 
(F1,14.65=5.59, P=0.032). The expression of MR was too low in the E20 frontal lobe for formal 
analysis. In the adult brain, MR expression was unaltered in the hippocampus but significantly 
increased in the PFC of prenatally Dex-treated rats,  (F1,13.57=6.45, P=0.024).  
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Figure 5.2 Candidate gene expression in the brain 
There was an effect of prenatal Dex treatment to decrease the expression of Egr1 in 
the E20 frontal lobe (A) while increase its expression in the adult PFC (B). There was 
an increased MR expression in the adult PFC (B) and an increased GR expression in 
the adult hippocampus (C) of prenatally Dex-exposed animals. Data are presented as 
mean  S.E.M. n=8-10/group. * P< 0.05 versus control. 
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5.3.2 Validation of results from next generation RNA sequencing 
The next generation RNA-seq data were processed by Dr Andreas Heger through the MRC 
CGAT programme. Three differential analytical tools were used to identify differences in 
mRNA levels of individual genes between control and experimental samples including DESeq, 
edgeR and Cuffdiff. Each of these methods generated different lists of regulated genes and 
was associated with high rates of false positive (Cuffdiff) and false negative (DESeq) 
discovery, however in general these methods had fairly good agreement, and most of the genes 
considered differentially expressed were shared between methods.  
 
One problem with RNA-seq was its small size number with n=4 per group, and the results in 
general did not cluster very well by group. I thus identified a list of genes from those that were 
consistently identified as differentially expressed whichever statistical method was used 
(Table 5.3 and Table 5.4), and thereafter validated the mRNA expression on a larger number 
of adult PFC samples (n=CON:9, DEX:10) using qPCR. The increased expression of Arc in 
the PFC of prenatally Dex-exposed rats was validated by qPCR (F1,11.25=7.47, P=0.019), 
however the expression of other genes on the list was not validated. (Figure 5.3) 
 
 117 
Gene name Description Gene function  Fold_change P value 
Gnas GNAS complex locus  maternally imprinted gene, circadian gene, involved in sleep, cognition, fear 
conditioning consolidation (Lassi et al., 2012) 
-5.902371761 7.66E-18 
 
Calcr calcitonin receptor  brain-specific maternally imprinted gene, possibly involved in pain modulation, 
serotonergic pathways, related to autism (Hoshiya et al., 2003) 
-4.840227599 4.93E-15 
Dlk1 delta-like homolog 1 paternally imprinted gene -1.24981 0.00343077 
Isl1 ISL LIM homeobox 1  expressed in forebrain, involved in cholinergic pathway, regulates cognitive 





Gpr101 G protein-coupled 
receptor 101 
expressed predominantly in the brain (limbic, autonomic and sensory areas), 






Ngfr nerve growth factor 
receptor 




Nts neurotensin modulates dopaminergic neurotransmission (Binder et al., 2001) -2.25287461 2.69E-13 
 
Table 5.3 Top list of down-regulated genes from adult PFC RNA-Seq   
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Gene name Description Gene function  Fold_change P value 
Arc activity-regulated cytoskeleton-
associated protein  
involved in synaptic plasticity (Lyford et al., 1995) 1.70081 5.00E-05 
Gfral GDNF family receptor alpha like involved in maturation and survival of differentiated 





Th tyrosine hydroxylase  involved in catecholamine biosynthesis  1.27928801 0.002060492 
Qrfpr pyroglutamylated RFamide peptide 
receptor  
involved in regulating neuroendocrine function, feeding 









Table 5.4 Top list of up-regulated genes from adult PFC RNA-Seq  
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Figure 5.3 Validation of differentially expressed genes from RNA-Seq in adult PFC 
using qPCR  
The expression of a number of down-regulated genes from RNA-Seq was not 
validated by qPCR (A). The increased expression of Arc in the PFC of prenatally Dex-
exposed rats was validated by qPCR (P=0.019), however the expression of other up-
regulated genes from RNA-Seq was not validated (B). Data are presented as mean  
S.E.M. n=9-10/group. * P< 0.05 versus control. 
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5.3.3 Arc expression in the brain 
Since there was an increased expression of Arc in the adult PFC of prenatally Dex-treated rats, 
I further investigated the expression of Arc in the E20 frontal lobe and adult hippocampus 
samples. There was no effect of prenatal Dex treatment on Arc expression in the E20 frontal 
lobe. However, there was an increased Arc transcription in the adult hippocampus of prenatally 
Dex-exposed rats, (F1,10.93=6.66, P=0.026). (Figure 5.4) 
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Figure 5.4 Arc expression in the brain 
There were no differences between the groups in Arc expression in the E20 frontal 
lobe (A); Arc expression was significantly increased in the adult hippocampus of 
prenatally Dex-exposed rats (P=0.026) (B). Data are presented as mean  S.E.M. n=8-
10/group. * P< 0.05 versus control.  
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5.3.4 DNA methylation at the Arc promoter and intragenic regions 
Figure 5.5 demonstrates the distribution of cytosine methylation at individual CpG sites in the 
analysed regions of the Arc gene. The efficiency of bisulfite conversion was calculated based 
on conversion rates of non-CpG cytosines and was around 90%.  
 
There were no effects of prenatal Dex treatment on DNA methylation at Arc promoter 
(detected by Arc_P1 and Arc_P2) and intragenic regions (detected by Arc_GB1 and Arc_GB2) 
in the E20 frontal lobe (A) and adult PFC (B). The percentage of DNA methylation varied 
between 3% to 35% across analysed CpGs, and the pattern of DNA methylation was similar 











Figure 5.5 DNA methylation at the Arc gene promoter and intragenic regions 
There were no significant differences between the two experimental groups in Arc 
methylation at the promoter and intragenic regions in either the E20 frontal lobe (A) 
or adult PFC (B). The DNA methylation pattern at the examined 34 CpG sites was 
similar between the E20 frontal lobe and adult PFC (C). Data are presented as mean 
 S.E.M. n=8-10/group.  
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5.4 Discussion 
In the present study, I investigated possible molecular correlates of behavioural phenotypes 
induced by prenatal Dex exposure in rats. I examined the baseline expression of candidate 
genes involved in synaptic plasticity and memory formation in dissected brain regions of the 
prenatal Dex-exposure animal model. I also validated the results of next generation RNA-Seq 
on adult PFC samples by qPCR and further investigated the possible epigenetic mechanisms 
associated with altered Arc expression. My results revealed altered brain expression of genes 
involved in synaptic plasticity and memory formation in prenatally Dex-exposed animals, with 
no indication of regulation by promoter DNA methylation.  
 
In my current experiment, there was an increased GR transcription in the adult hippocampus 
of prenatally Dex-exposed rats. This result appears to contrast with some previous studies, in 
which prenatal glucocorticoid exposure was found to permanently decrease GR expression in 
the hippocampus (Welberg et al., 2001, Levitt et al., 1996). However, there is evidence that 
prenatally Dex-exposed rats reared by control mothers are found to have increased 
hippocampal GR mRNA and enhanced glucocorticoid feedback (Brabham et al., 2000). In my 
current experiment, the increased hippocampal GR mRNA in the adult hippocampus of 
prenatally Dex-exposed rats could potentially due to random environmental enrichment at 
neonatal time. The increased GR expression in the hippocampus of prenatally Dex-treated rats 
may facilitate HPA axis feedback and is consistent with the normal basal and stressed-induced 
CORT response in these animals.  
 
Prenatal Dex exposure increased the expression of MR in the adult PFC. This is potentially 
interesting considering the role of MR in behavioural adaptation and strategy (Oitzl and de 
Kloet, 1992). Ablation of forebrain MR expression in mice has been shown to result in 
impaired behavioural responses to changes in task-requirements in the water maze, consistent 
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with behavioural perseverance and stereotypy (Berger et al., 2006). In my current study, an 
increased MR expression in the adult PFC of prenatally Dex-exposed rats is potentially 
consistent with facilitation of PFC-associated behavioural flexibility in the reversal learning 
and the DMTP task (chapter 4).   
 
My current results suggest prenatal Dex exposure had no effect on brain Bdnf expression. 
However, there was an increased expression of Egr1 in the adult PFC, with a trend towards 
increased expression in the adult hippocampus of prenatally Dex-exposed rats. In contrast, 
Egr1 expression was significantly decreased in the E20 frontal lobe of Dex-treated fetuses, 
indicating its expression may be differentially regulated at different developmental stage. As 
described in 5.1, Egr1 is one of the IEGs that has been implicated in experience-dependent 
synaptic plasticity. My current results of altered Egr1 expression in the E20 and adult brains 
suggest that prenatal stress may affect cognitive and memory processes through programming 
effects on synaptic development and connectivity.   
 
In addition to candidate gene approach, I also prepared samples and sent for next generation 
RNA-Seq to characterize the adult PFC transcriptome of the prenatal Dex exposure model, 
which revealed differentially expressed genes implicated in synaptic plasticity, cognition, 
dopaminergic, serotonergic and cholinergic pathways. Validation of the sequencing results 
confirmed increased expression of Arc mRNA in the adult PFC and hippocampus of prenatally 
Dex-treated rats.  
 
The increased expression of Arc in the adult brain of prenatally Dex-exposed rats is interesting. 
ARC protein is an important component of the N-methyl-D-aspartate (NMDA) receptor 
signalling complex at the postsynaptic membrane of glutamatergic synapses (Korb and 
Finkbeiner, 2011) and there is evidence that prenatal stress induces programming effects on 
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the NMDA receptor signalling complex. For example, one previous study reported that 
prenatal stress in rats induces significant changes in genes associated with the NMDA 
receptor/postsynaptic density complex (Kinnunen et al., 2003). Another group reported that 
prenatal stress produces learning deficits associated with impaired NMDA receptor-mediated 
LTP in the hippocampus (Son et al., 2006). Furthermore, schizophrenia patients were found 
to have an enrichment of de novo mutations involved in genes belonging to components of the 
NMDA receptor signalling complex including Arc (Kirov et al., 2012, Fromer et al., 2014).  
 
In addition, an increased brain expression of Arc is potentially consistent with an increased 
brain Egr1 expression in prenatally Dex-exposed rats. Indeed, previous studies report 
synchronized regulation of IEGs expression such as Arc and Egr1 in rats in response to 
learning, and the level of Arc mRNA in the hippocampal neurons correlates with animal 
performance on hippocampus-associated cognitive tasks (Guzowski et al., 2001). In my 
current experiment, an increased brain expression of Arc and Egr1 in prenatally Dex-exposed 
rats is potentially consistent with facilitation of the reversal learning and the DMTP task. 
Taken together, the current results highlighted a central role of synaptic function in prenatal 
glucocorticoid programming, suggesting that prenatal glucocorticoid exposure may influence 
the synaptic development of the offspring, leading to permanent alterations in synaptic 
strength and brain function, and thus inducing increased vulnerability to neuropsychiatric 
disorders in later life.  
 
In an effort to elucidate the possible role of promoter DNA methylation in mediating the long-
term effects of prenatal Dex exposure on brain Arc transcription, I examined DNA methylation 
across 4 loci of the Arc promoter and intragenic regions in the E20 and adult PFC samples 
using direct bisulfite Pyrosequencing. 
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The Arc gene CpG rich regions encompass both the promoter and the intragenic region. I 
examined 34 individual CpG sites that span the promoter region (detected by Arc_P1 and 
Arc_P2) and the downstream CDS region (detected by Arc_GB1 and Arc_GB2). Overall there 
was no effect of prenatal Dex treatment on DNA methylation at the examined CpG sites in 
both the E20 and adult PFC. The pattern of DNA methylation at these CpG sites was similar 
between the E20 and adult PFC. The average site-specific methylation levels at the promoter 
and intragenic regions ranged between 3% and 35%, which is compatible with a previous study 
(Penner et al., 2011). Thus, it seems that the Arc gene region may be constitutively methylated 
at low levels and DNA methylation may not correlate with gene expression. It is therefore 
likely that other epigenetic regulatory mechanisms such as histone modifications, instead of 
DNA methylation, may be responsible for determining the altered Arc expression in prenatally 
Dex-exposed rats.  
 
In summary, my current experiment suggest that prenatal Dex exposure in rats induces long-
term changes in brain gene expression involved in synaptic plasticity and memory formation, 
providing evidence that alterations in brain GR/MR expression and synaptic function may 











Chapter 6 Mechanisms of programming:  Insights 




Epigenetic dysregulation represents a plausible link between early life experience and long-
lasting effects on cognition and mental health. As discussed in 1.4.2.1, there is evidence that 
the epigenetic signatures of the entire mammalian genome (epigenome) undergo precise, 
coordinated reprogramming at distinct stages of development. These developmental 
reprogramming events are characterized by remarkable changes of epigenetic marks, which 
may render these time points more susceptible to environmental perturbations compared to the 
fully differentiated state. Evidence of environmental influence on the epigenome during 
development is discussed in 1.4.3.  
 
During developmental reprogramming, two epigenetic-related processesretrotransposition 
and parental imprintingundergo specific epigenetic control. They are exempted from the 
first wave of global DNA demethylation for the benefit of repression of transposon activities 
and maintaining parental imprinting (Seisenberger et al., 2013). Environmental perturbations 
such as Dex exposure during this critical time may have an influence on these two tightly 
regulated processes, and thus endanger genomic integrity and affect brain development and 
function.  
 
Apart from developmental period, the activities of these two processes are still regulated and 
maintained mainly by epigenetic mechanisms and disrupted processes of each have been 
implicated in neuropsychiatric disorders (discussed below in 6.1.1 and 6.1.2).  
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6.1.1 Transposable elements (TEs) 
Transposable elements (TEs) are mobile DNA pieces that can move and spread within (and 
sometimes between) genomes. They are classified by whether they mobilize via a DNA (DNA 
transposons) or an RNA (retrotransposons) intermediate. Retrotransposons are then further 
divided into long terminal repeat (LTR) and non-LTR retrotransposons depending on whether 
they contain or lack a LTR. DNA transposons move through a ‘cut-and-paste’ mechanism, 
whereas retrotransposons move through a ‘copy-and-paste’ mechanism via reverse 
transcribing and inserting into new genomic locations (Cordaux and Batzer, 2009).  
 
Over the course of evolution most TEs have lost their ability to mobilise, however non-LTR 
retrotransposons, including the long interspersed element-1 (L1 or LINE-1) are the only TEs 
that are currently active in the human genome today (Cordaux and Batzer, 2009). As a result 
of their persistent activity and accumulation over tens of millions of years, these non-LTR 
retrotransposons have had a dramatic influence on the evolution of primate genomes (Cordaux 
and Batzer, 2009). TE mobilizations contribute to genomic innovations by generating genomic 
instability and rearrangements such as deletions, duplications and inversions (Levin and 
Moran, 2011). In addition, their insertions into the genome can influence genomic function by 
affecting the expression of nearby genes (Han et al., 2004). These retrotransposition events are 
important drivers for evolution (Kazazian, 2004), but at the same time pose threats to the 
genomic integrity and human health (Belancio et al., 2008).   
 
Among them, L1s are the only autonomous TEs (able to mobilize on their own) in the human 
genome. There are about 500,000 copies of L1 in human genome, accounting for 17% of its 
DNA content (Lander et al., 2001). The canonical L1 element consists of two open reading 
frames (ORF1 and ORF2) flanked by a 5′ untranslated region (UTR) containing an internal 
RNA polymerase II (RNAPII) promoter and a 3′ UTR containing an oligo(dA)-rich tail (AAA) 
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preceded by a polyadenylation signal. ORF1 encodes a RNA-binding protein and ORF2 
encodes a protein with endonuclease and reverse-transcriptase activities (Babushok and 
Kazazian, 2007). However of the 500,000 L1 copies most are not active due to truncations, 
internal rearrangements and mutations within the ORFs, and it has been estimated that only an 
average of 80-100 L1 copies are actually competent for retrotransposition in the human 
genome (Brouha et al., 2003). In addition, their retrotransposition activities are further 
regulated by various cellular processes including transcriptional and post-transcriptional 
silencing (Rodic and Burns, 2013).   
 
Despite these defensive mechanisms, L1 retrotransposition events occur in the germ line and 
during embryogenesis (Kano et al., 2009), leading to heritable and non-heritable genetic 
diseases (Chen et al., 2005, Kazazian et al., 1988). The rate of this has been estimated as 
approximately 1 insertion for every 20 births in humans based on disease-causing de novo 
insertions (Kazazian, 1999). In addition, there is evidence that L1 retrotransposition activities 
take place in somatic tissues (Belancio et al., 2010), which are potentially mutagenic and have 
been implicated in the pathogenesis of cancer (Iskow et al., 2010, Rodic and Burns, 2013).  
 
However, recent studies suggest high levels of L1 expression and retrotransposition take place 
in neuronal progenitor cells under physiological conditions in rodents and humans, which 
might contribute to neuronal differentiation and neuronal somatic mosaicism (Muotri et al., 
2005). Indeed, increased copies of L1 were found in adult brain tissues compared to other 
peripheral tissues (Coufal et al., 2009). In addition, L1 retrotransposition in the hippocampus 
has been implicated in experience-dependent neuronal plasticity in mice (Muotri et al., 2009). 
However, dysregulation of L1 activities, possible via epigenetic processes, has also been 
associated with neurodevelopmental diseases (Bundo et al., 2014, Muotri et al., 2010). 
In summary, L1 expression and retrotransposition occur during embryogenesis and in the adult 
brain. Despite possible benefit for brain development, neuronal diversity and behaviour 
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(Singer et al., 2010), these retrotransposition events are potentially mutagenic. Dysregulated 
L1 activities, triggered or precipitated by prenatal events, may be involved in mediating the 
increased risk for later neuropsychiatric disorders (Thomas et al., 2012).  
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6.1.2 Imprinted genes 
Imprinted genes are defined by their parent of origin specific monoallelic expression as a 
consequence of differential epigenetic markings of the paternal and maternal alleles 
established during parental gametogenesis (Reik and Walter, 2001). Many imprinted genes are 
highly expressed in the brain (Davies et al., 2005). Brain-expressed imprinted genes are crucial 
not only to early development, but also to brain function and behaviour (Kopsida et al., 2011).  
 
Multiple lines of evidence suggest aberrant genomic imprinting play a role in neuropsychiatric 
disorders. The first evidence comes from studies of single-locus syndromes that have a well-
understood molecular basis of disrupted genomic imprinting, including Prader-Willi 
syndrome, Angelman syndrome, Turner syndrome and Rett syndrome (Kopsida et al., 2011). 
These genetic syndromes encompass essential endophenotypes of neuropsychiatric disorders, 
including stereotyped behaviours, behavioural inflexibility, attentional deficits, cognitive 
deficits, psychosis, language and social impairments (Badcock and Crespi, 2006). The 
genomic basis to these individual endophenotypes is however not clear.  
 
Evidence linking genomic imprinting to neuropsychiatric disorders also comes from the study 
of ASD. Firstly, autistic-like behaviour is commonly found in subjects with Angelman 
syndrome (AS) and Rett syndrome (Summers et al., 1995, Weaving et al., 2005). The 
incidence of AD is found much higher in individuals with these single-locus syndromes 
(Cohen et al., 2005). In addition, the chromosomal regions that linked to ASD on genome 
scans encompass those imprinted regions that have been implicated in AS (15q11-q13) (Cook 
et al., 1997) and Rett syndrome (7q22) (Cukier et al., 2009), suggesting common molecular 
lesion involving aberrant genomic imprinting may underlie these phenotypically related 
disorders (Kopsida et al., 2011).  
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Moreover, it has been suggested that genomic imprinting may contribute to the sex-bias in 
incidence rate and clinical presentations of related neuropsychiatric disorders. The idea is that 
males inherit a single X chromosome from their mother, thus that paternally expressed X-
linked imprinted genes are never expressed in males. On the other hand, females inherit X 
chromosomes from both their parents and the expression of X-linked imprinted genes from 
paternal or maternal genomes depend on their X-inactivation status (Davies et al., 2006). 
Studies with Turner syndrome suggest that paternally and maternally X-linked imprinted 
genes have disparate effects on cognitive and behavioural phenotypes (Davies et al., 2006, 
Skuse et al., 1997), therefore they may contribute to the sex differences in vulnerability and 
presentation of neuropsychiatric disorders. Collectively, the above evidence supports the 
hypothesis that imprinted genes are implicated in the pathogenesis of neuropsychiatric 
disorders.  
 
Imprinted genes usually cluster into large chromosomal domains, with maternally expressed 
genes alongside paternally expressed genes. Imprinting within these clusters is often regulated 
by differentially methylated regions (DMRs), especially the primary germ-line derived DMRs, 
in which the differential methylation is laid down in the germlines (Edwards and Ferguson-
Smith, 2007). By contrast, secondary DMRs are those where differential methylation is 
established after fertilization. These secondary DMRs sometimes coordinate with the primary 
DMRs in the regulation of imprinted gene expression. For example, the imprinting control 
at the Igf2/H19 region depends on long range chromatin interactions mediated by 
transcriptional repressors between the primary H19-DMR and the secondary Igf2-DMRs 
(Lopes et al., 2003). The Dlk1-Dio3 imprinting region also contains a primary intergenic 
germline-derived DMR (IG-DMR) located 75 kb downstream of Dlk1, and a secondary Gtl2-
DMR. Both DMRs are hypermethylated on the paternal allele and hypomethylated on the 
maternal allele in somatic cells. The IG-DMR is shown to function at the top of the hierarchy 
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and controls the methylation pattern of this imprinted gene cluster (Lin et al., 2003, Takada et 
al., 2002).  
 
In the current project, I investigated the developmental and tissue-specific expression of 
several candidate imprinted genes in the E20 frontal lobe, adult PFC and adult hippocampus 
of the prenatal Dex exposure rat model. Loci of interest included: the Dlk1-Gtl2 region located 
on human chromosome 14q32 (mouse distal 12), the Prader-Willi/Angelman (PWS/AS) 
region located on human chromosome 15q11-13 (mouse 7C), the Grb10 region located on 
human chromosome 7p11.2-p13  (mouse 11) and the Igf2/Cdkn1c region located on human 
chromosome 11p15 (mouse 7). I further explored the possible effect of prenatal Dex treatment 
on DNA methylation at the Igf2-DMR2 and IG-DMR region using bisulfite Pyrosequencing.  
 
Dlk1-Dio3 region 
The Dlk1-Dio3 locus harbours at least three paternally expressed protein-coding genes (Dlk1, 
Rtl1, and Dio3), and seven maternally expressed ncRNAs (Meg3/Gtl2, Anti-Peg11, Meg8, 
Irm/‘‘Rian’’, AK050713, AK053394 and Meg9/Mirg) (Hagan et al., 2009). I investigated the 
expression of three candidate genes within this cluster, including delta-like homolog 1 (Dlk1), 
iodothyronine deiodinase 3 (Dio3) and gene-trap locus 2 (Gtl2 or Meg3).  
 
DLK1 is a member of the Notch signalling pathway(da Rocha et al., 2008) and has been 
implicated in the differentiation of midbrain dopaminergic neurons (Christophersen et al., 
2007). It is paternally expressed and its expression can be found in many adult mouse tissues, 
including brain, kidney, testis, and thymus (Hagan et al., 2009). DIO3 encodes a protein that 
protects developing tissues from excessive amounts of thyroid hormone (Tsai et al., 2002). 
Dio3 is preferentially expressed from the paternal allele in the mouse fetus (Hernandez et al., 
2002) and it is less expressed in the adult brain than other tissues (Tierling et al., 2006). MEG3 
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(Gtl2 in mouse) encodes a long noncoding RNA (lncRNA) that has a putative role of tumour 
suppressor (Zhou et al., 2012). Gtl2 is maternally expressed and is highly expressed in the 
adult mouse brain (Tierling et al., 2006).  
 
Prader-Willi /Angelman region (PWS/AS region) 
Prader–Willi syndrome (PWS) and Angelman syndrome (AS) are caused by reciprocal 
deficiency of imprinted gene expression from the paternal and maternal alleles at human 
chromosome 15q11-q13, Clinically this locus is associated with a variety of behavioural and 
cognitive endophenotypes found in PWS/AS and related neuropsychiatric disorders, including 
aggression, behavioural inflexibility, attention deficits and psychosis (Soni et al., 2007).  
 
The PWS/AS region harbours a cluster of imprinted genes, including the paternally expressed 
gene small nuclear ribonucleoprotein polypeptide N (SNRPN) and maternally expressed gene 
ubiquitin-protein ligase E3A (UBE3A). SNRPN is the most complex gene in the region, 
consists of 10 exons and serves as a host for a number of small nucleolar RNA (snoRNA) 
genes, including SNORD116 (also known as HBII/RBII/mbii-85), which has been linked to 
key characteristics of the PWS phenotype (Buiting, 2010). On the other hand, UBE3A is the 
AS gene and is maternally expressed in the human brain. UBE3A has been implicated in 
ubiquitination of tumour suppressor protein p53 (Scheffner et al., 1993) and a number of other 
proteins involved in DNA repair and cell-cycle progression (Srivenugopal and Ali-Osman, 
2002). In addition, UBE3A also function as a steroid receptor co-activator that might modulate 
the effects of sexual hormones on brain development and function (Wilkinson et al., 2007).  
 
This region is conserved on mouse chromosome 7. Similar to humans, Snrpn is paternally 
expressed in the mouse brain and imprinted into adulthood (Runte et al., 2004). By contrast, 
the monoallelic expression of Ube3a in the mouse brain is confined to distinct areas such as 
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Purkinje neurons, the hippocampus and the mitral cells of the olfactory bulb. Ube3a exhibits 
biallelic expression in other parts of the brain and in other tissues (Albrecht et al., 1997).  
 
Grb10 region 
Growth factor receptor-binding protein 10 (GRB10) is mapped to human chromosome 7p11.2-
p13 and has been suggested as a candidate gene for Silver-Russell syndrome (SRS), which is 
characterized by pre- and postnatal growth failure (Monk et al., 2000). GRB10 encodes a SRC 
homology domain 2 (SH2)-containing adaptor protein, which can bind to several tyrosine 
kinases and growth receptors (He et al., 1998, Mano et al., 1998). It has been postulated that 
GRB10 is involved brain development by interacting with these receptors and downstream 
signalling molecules.  
 
The mouse homologue (Grb10/Meg1) maps to the imprinted region of proximal mouse 
chromosome 11. It is preferentially expressed from the maternal allele in the periphery and 
loss of expression leads to significant fetal and placental overgrowth (Charalambous et al., 
2003). By contrast, Grb10 is paternally expressed in the mouse brain from fetal to adult life 
(Arnaud et al., 2003) and ablation of this imprinting in the brain leads to increased social 
dominance (Garfield et al., 2011). Thus, Grb10 appears to influence distinct physiological 
processes, fetal growth and adult behaviour, by reciprocal expression from the two parental 
alleles in different tissues (Garfield et al., 2011, Monk et al., 2009).  
 
Igf2 and Cdkn1c region  
The human chromosome 11p15 harbours two clusters of imprinted genes involved in the 
regulation of prenatal growth. This imprinted region is conserved on mouse chromosome 7. In 
my study, I investigated the expression of insulin-like growth factor 2 (Igf2) and cyclin 
dependent kinase inhibitor 1C (Cdkn1c) from this imprinted region in my rat model.  
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Igf2 and Cdkn1c have antagonistic effects on growth, with the paternally expressed Igf2 gene 
encoding an embryonic growth factor that promotes placental and embryonic growth 
(Randhawa and Cohen, 2005) and the maternally expressed Cdkn1c gene encoding a negative 
regulator of cell proliferation that inhibits growth (Andrews et al., 2007). In addition to its role 
in brain growth and development (Pidsley et al., 2010), there is evidence that Igf2 is involved 
in important brain functions including memory consolidation and enhancement in rats (Chen 
et al., 2011). The imprinting status of Igf2 is heterogeneous in the brain. In humans, IGF2 
exhibits biallelic expression in the fetal brain and a complex regional-specific parental allelic 
effect in the adult brain (Pham et al., 1998). In mouse, it has been reported that Igf2 expression 
demonstrates a paternal bias in the fetal brain and a maternal bias in the adult PFC and 
hypothalamus regions (Gregg et al., 2010).  
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6.1.3 Hypotheses and aims 
I hypothesise that fetal overexposure to glucocorticoids during pregnancy may modulate the 
epigenetic signatures of the brain, and the effect of which may be maintained through 
subsequent cell divisions and persist into adult life. In particular, I hypothesise that prenatal 
glucocorticoid overexposure may affect the epigenetic regulation of important processes 
during development, leading to sustained alterations in retrotransposon activities and 
imprinted gene expression in the brain, and therefore interfering with brain function and 
behaviour. 
 
In this chapter I aimed to explore the possible effects of prenatal Dex treatment on candidate 
gene expression involved in retrotransposon activities and genomic imprinting. I also aimed 
to study the prenatal glucocorticoids effects on DNA methylation at regulatory regions of 
imprinted genes by direct bisulfite Pyrosequencing. Collectively, these experiments may 





6.2.1 Quantitative real-time PCR 
The same cDNA samples as described in 5.2.3 were used here for gene expression analysis. 
Briefly, 800ng of total RNA was obtained (n=CON:10, DEX:8 for E20 frontal lobe; n=CON:9, 
DEX:10 for adult PFC; n=CON:10, DEX:10 for adult hippocampus), DNAse-treated and 
converted to cDNA. The qPCR was performed as described in 2.3.4.2, using self-designed 
UPL™ assays, PrimeTime® qPCR assays or Taqman® primer-probe mix. Data were 
normalized to Hprt for adult hippocampus samples, and to the mean of the three housekeeping 
genes (Hprt, G6pd and Tbp) for the E20 and adult PFC samples. 
 
6.2.2 DNA methylation analysis 
The same bisulfite-treated DNA samples as described in 5.2.5 were used here for DNA 
methylation analysis (n=CON:10, DEX:10 for E20 frontal lobe and n=CON:8, DEX:9 for 
adult PFC). 1l of bisulfite converted DNA samples were amplified using primers that targeted 
either the Igf2-DMR2 or the IG-DMR region. Schematic diagram of the methylated regions 
for analysis is demonstrated in Figure 6.1. PCR conditions were optimized for each assay to 
ensure a clear band of product with sharp contrast to any primer-dimer band (Table 6.1 and 
Table 6.2). PCR program consisted of rapid heating to 95°C for 10 minutes followed by 45 
cycles of 20 seconds of denaturation at 95°C, 20 seconds of annealing at 56°C and 20seconds 
of elongation at 72°C. The samples were then cooled down to 72°C for 7 minutes for 
completion. Methylation of DNA was measured by Pyrosequencing using the PyroMark Q24 
system (Qiagen) as described in 2.3.5.3. 
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6.2.3 Statistical analysis 
Data were analysed using GLMs (JMP statistical software, SAS Institute, Cary, NC, USA). 
All data were checked for homogeneity of variance and normality of distribution. All statistical 
models investigated the main effect of Group. Litter (nested within group) was fitted as 
random variable to account for the use of more than one animal per litter. Data were presented 





Figure 6.1 Schematic map of the Igf2/H19 region and Dlk1/Dio3 region 
The arrow above a gene indicates the direction of transcription. The paternal allele is 
represented on the top and the maternal allele is on the bottom. DMRs are 
represented by small circles: a solid one indicates hypermethylation and an empty 
one indicates hypomethylation. In the current study, DNA methylation was assessed 






IG-DMR1.3 IG-DMR2.3 IG-DMR2.4 
IG-DMR3.2 
AmpliTaq MM 10μl 10μl 10μl 10μl 
Primer mix (2μM) 3μl  2μl 5μl 4μl 
DNA  1μl 1μl 1μl 1μl 
Nuclease free water 6μl 8μl 4μl 5μl 
 








IG-DMR1.3 IG-DMR2.3 IG-DMR2.4 
AmpliTaq MM 10μl 10μl 10μl 10μl 
Primer mix (2μM) 3μl  2μl 5μl 4μl 
DNA  1μl 1μl 1μl 1μl 
Nuclease free water 6μl 8μl 4μl 5μl 
 
Table 6.2 Optimised pyrosequencing PCR recipes for adult PFC samples 
 
6.3 Results 
6.3.1 L1 expression in the brain 
There was no effect of prenatal Dex treatment on L1 expression in the E20 frontal lobe. 
However, the level of L1 transcripts was significantly increased in the adult brain of prenatally 
Dex-exposed rats: there was an increased mRNA expression of L1 transcript ORF2 
(F1,13.06=9.80, P=0.008) and Rat1 (F1,11.08=4.85, P=0.050) in the adult PFC, while  there was 
increased expression of all three L1 transcript variants ORF2 (F1,13.90=7.36, P=0.017), Rat1 
(F1,12.49=13.20, P=0.003) and Rn1 (F1,14.79=18.16, P=0.001) in the adult hippocampus of 






Figure 6.2 L1 expression in the brain 
There was no difference between the two experimental groups in L1 expression in 
the E20 PFC (A); prenatal Dex exposure had an effect to increase mRNA expression of 
L1 transcripts in the adult PFC (B) and hippocampus (C). Data are presented as mean 
 S.E.M. n=8-10/group. * P< 0.05 versus control, ** P< 0.01 versus control.  
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6.3.2 Imprinted gene expression in the brain 
There were no significant differences between the groups in brain expression of imprinted 
genes Dlk1, Dio3, Gtl2, Snrpn, RBII85, Ube3a, Igf2 and Cdkn1c in the E20 frontal lobe, 
though there was a trend towards decreased expression of Grb10 in the frontal lobe of Dex-
treated embryos, (F1,7.33=5.22, P=0.055). In the adult brain, prenatal Dex treatment had no 
obvious effect on imprinted gene expression in the PFC, however it had a broad impact on 
imprinted gene expression in the adult hippocampus. There was an increased hippocampal 
expression of Dlk1 (F1,14.35=6.67, P=0.021), RBII85 (F1,1.83=45.76, P=0.027), Grb10 
(F1,14.73=6.44, P=0.023), Cdkn1c (F1,14.99=5.86, P=0.029), and a trend towards increased 




Figure 6.3 Imprinted gene expression in the brain 
There was no effect of prenatal Dex exposure on brain imprinted gene expression in 
the E20 frontal lobe (A) and adult PFC (B); prenatal Dex exposure increased the 
expression of Dlk1, RBII-85, Grb10 and Cdkn1c in the adult hippocampus (C). Data are 
presented as mean  S.E.M. n=8-10/group. * P< 0.05 versus control. 
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6.3.3 DNA methylation at the Igf2-DMR2 region 
Figure 6.4 demonstrates the DNA methylation level at 9 individual CpG sites of the Igf2-
DMR2 region. The efficiency of bisulfite conversion was calculated based on conversion rates 
of non-CpG cytosines and was around 90%.  
 
There was no effect of prenatal Dex treatment on DNA methylation at the Igf2-DMR2 region 
in the E20 frontal lobe (A) and adult PFC (B). The level of DNA methylation averaged at 
25.26 ± 14.87% for the E20 frontal lobe and 32.48 ± 14.13% for the adult PFC over the 




Figure 6.4 DNA methylation at the examined 9 CpG sites at Igf2-DMR2  
There were no effects of prenatal Dex exposure on DNA methylation at Igf2-DMR2 in 




6.3.4 DNA methylation at the IG-DMR region 
Figure 6.5 demonstrates the DNA methylation level at 6 CpG-rich loci at the IG-DMR region, 
which is the primary regulatory region for the imprinted Dlk1-Dio3 locus. The efficiency of 
bisulfite conversion was calculated based on conversion rates of non-CpG cytosines and was 
around 90%.  
 
There was no significant effect of prenatal Dex treatment on DNA methylation at IG-DMR in 
the E20 frontal lobe (A) and adult PFC (B). The average DNA methylation level at IG-DMR 




Figure 6.5 DNA methylation at the examined 6 CpG-rich loci at IG-DMR 
There was no effect of prenatal Dex exposure on DNA methylation at IG-DMR in the 




In the present study, I investigated the effect of prenatal Dex administration on two epigenetic-
related processes: retrotransposition and genomic imprinting. I examined the developmental 
stage- and regional-specific expression of L1 and candidate imprinted genes in dissected brain 
regions of the prenatal Dex exposure rat model. I also studied the DNA methylation at DMRs 
of the Dlk1-Dio3 and Igf2 imprinted regions. My results suggest that prenatal Dex exposure 
induced increased L1 transcription in the adult but not the E20 brain and had developmental 
stage- and regional-specific effects on brain imprinted gene expression in the male offspring.  
 
My results revealed an increased expression of L1 in the adult brain of prenatally Dex-treated 
rats. There was unanimously increased expression of ORF2 but variable expression of the 
other two L1 transcript variants at different brain regions of prenatally Dex-exposed adult rat 
offspring. This is not surprising since ORF2 picks up any generic L1 copies including those 
truncated versions being transcribed from neighbouring gene promoters, whereas Rat1 and 
Rn1 target at the 5' UTR and only pick up copies that are being transcribed from their own 
promoters. The increased brain L1 transcription was only evident in adult, but not at an earlier 
developmental stage (E20), suggesting that prenatal Dex treatment may induce susceptibility 
for increased L1 transcription in later life. 
 
My current results are relevant to several previous studies. For example, in a recent study 
researchers reported that prenatal treatment with poly I:C to pregnant dams induces increased 
L1 copies in mice offspring (Bundo et al., 2014). The same group of researchers also reported 
increased L1 ORF2 copy number in neurons from postmortem PFC of schizophrenia patients. 
Further evidence indicates brain-specific L1 insertions in these patients preferentially affect 
genes related to synaptic function and schizophrenia (Bundo et al., 2014). In addition, there is 
evidence that disrupted epigenetic regulatory processes induce an increased susceptibility for 
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L1 transcription and retrotransposition in rodents and cells derived from human patients with 
Rett syndrome (Muotri et al., 2010).  
 
The implications of the above evidence are several fold: a) prenatal environmental factors 
induce long-term susceptibility for increased L1 transcription and retrotransposition; b) 
epigenetic processes are involved in regulating L1 activities; c) increased L1 activities are 
potentially implicated in the pathogenesis of schizophrenia. Together with my current results, 
the existing evidence supports the hypothesis that L1 retrotransposition activities may be 
implicated in prenatal programming of neuropsychiatric disorders.  
 
My current results on imprinted gene expression suggest that prenatal Dex treatment in rats 
had distinct effects on brain imprinted gene expression during development and in different 
regions of adult brain. For example, there was a trend towards decreased Grb10 expression in 
the E20 frontal lobe of Dex-treated fetuses, however in a previous study Grb10 was up-
regulated in Dex-exposed fetal liver using a same animal model (Drake et al., 2011). The 
distinct effect of Dex treatment on Grb10 expression in the fetal brain and liver may reflect its 
reciprocal pattern of imprinting in the brain (paternally expressed) and peripheral tissues 
(maternally expressed) (described in 6.1.2). In addition, my current results provided further 
evidence for the regional-specific parental allelic effects of brain imprinted gene expression, 
such that there was an increased Grb10 expression in the adult hippocampus but not PFC of 
prenatally Dex-exposed rats. Similarly, the expression of Dlk1 was significantly increased in 
the adult hippocampus of prenatally Dex-treated rats, but was down-regulated in the adult PFC 
according to the next generation RNA-Seq data (described in 5.3.2). These results together 
demonstrate the complex spatiotemporal-specific effect of prenatal Dex treatment on brain 
imprinted gene expression.   
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Interestingly, my results revealed an increased expression of RBII-85 in the adult hippocampus 
of prenatally Dex-exposed rats. As described in 6.1.2, RBII-85 (HBII-85 or SNORD116 in 
human) is one of the snoRNAs located in the introns of a large ‘host gene’ Snrpn and generated 
during the pre-mRNA splicing process. The specific effect of prenatal Dex treatment on 
hippocampal RBII-85 expression, but not on its host gene Snrpn, suggests the regulation of 
this gene may be important for prenatal Dex programming. Previous studies using single gene 
knock-out mice have associated RBII-85 function with core features of PWS phenotype such 
as growth and obesity (Skryabin et al., 2007), however it may also contribute to other atypical 
behavioural and cognitive phenotypes of PWS (Relkovic and Isles, 2013), such as attention 
deficits (Woodcock et al., 2009), working memory and executive impairments (Jauregi et al., 
2007). It is therefore possible that the aberrant hippocampal expression of RBII-85 in 
prenatally Dex-exposed rats may underlie some of the cognitive phenotypes observed on my 
previous behavioural measures.  
 
Imprinted genes play important roles in fetal growth and development. In a previous study that 
used a same rat model, researchers reported that prenatal Dex affects the expression of a 
number of growth-related imprinted genes in the placenta and fetal liver, with possible 
implications in fetal growth and subsequent birth weight (Drake et al., 2011). In my current 
study, there was no indication of prenatal Dex treatment effect on growth-related imprinted 
gene expression in the fetal brain, including Igf2 and Cdkn1c. The tissue-specific effect of 
prenatal Dex treatment on growth-related imprinted gene expression may indicate a protective 
mechanism of the organism for brain development, however this argument would be stronger 
if I had obtained additional evidence on brain weight of these animals.  
 
As described in 6.1.2, the somatic monoallelic expression of imprinted genes usually depends 
on the regulation of DMRs, whose differential methylation patterns are established during 
gametogenesis and after fertilization. Aberrant DNA methylation at these regulatory regions 
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is associated with a loss of imprinting and overexpression of related genes. In addition, there 
is evidence that prenatal environmental factors can affect the DNA methylation at DMRs (Tobi 
et al., 2012, Drake et al., 2011).  
 
Unfortunately due to a limitation in DNA samples, I was not able to explore the potential role 
of DNA methylation at DMRs in mediating the altered hippocampal imprinted gene expression 
in my prenatal Dex exposure rat model.  However, using my available brain DNA samples, I 
studied the DNA methylation level at Igf2-DMR2 and IG-DMR in the E20 frontal lobe and 
adult PFC in rats. As expected, there were no effects of prenatal Dex treatment on DNA 
methylation at both DMRs. The DNA methylation level averaged around 50% at IG-DMR in 
both E20 and adult PFC tissues, indicating that this region is differentially methylated in the 
frontal cortical region of the brain. Surprisingly, my results revealed that an average DNA 
methylation level around 30% at Igf2-DMR2 in the E20 and adult PFC, suggesting that this 
region is hypomethylated in the frontal cortical region of the brain. There was also a small 
increase in average DNA methylation level at both DMRs in the adult PFC compared to the 
E20 frontal lobe. While it may be true that these two DMRs become more methylated with 
aging, it could also be a reflection of different composition of brain cell types at different 
developmental stage, since different cell types may have different signatures at these DMRs.   
 
In summary, my current results suggest that prenatal exposure to Dex induced increased L1 
transcription in the adult brain. Prenatal Dex treatment also had spatiotemporal-specific effects 
on brain imprinted gene expression. Collectively, these results suggest that prenatal Dex 
exposure may induce long-term susceptibility to dysregulations in retrotransposon activities 












Chapter 7 Discussion 
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7.1 Summary 
The current study aimed to obtain experimental evidence on the long-term safety of antenatal 
glucocorticoid treatment in the clinic, and to justify the validity of using the prenatal Dex 
exposure rat model for studying neuropsychiatric conditions in humans. In this thesis, I 
investigated the long-term effect of prenatal Dex exposure during the last week of gestation in 
rats on stress responses and cognition in adult male offspring. I also studied the possible 
molecular mechanisms associated with the behavioural phenotypes. Finally, I explored the 
possible role of two epigenetic-related processes in mediating the prenatal Dex programming 
effects in rat offspring.  
 
The main findings of my current study can be summarized as below:  
1. Dex exposure during the last week of gestation reduced birth weight in rat offspring. 
The reduced body weight persisted till adulthood in male offspring.  
2. There was no effect of prenatal Dex exposure on a) basal and stress-induced plasma 
CORT levels and b) unconditioned fear and anxiety-related behaviour in the adult 
offspring.  
3. Prenatal Dex exposure affected cognition in the adult male offspring, including a) 
contextual fear conditioning and b) within-task flexibility on water maze tasks. 
However, spatial reference memory, working memory and attentional set-shifting was 
not affected by prenatal Dex treatment.  
4. The behavioural phenotypes were associated with altered expression of genes 
involved in synaptic plasticity and memory formation in the adult brain of prenatally 
Dex-exposed rats.  
5. Prenatal exposure to Dex induced increased L1 transcription and altered imprinted 
gene expression profile in the adult brain.  
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7.2 Discussion  
7.2.1 Behavioural results 
In this thesis, I investigated the long-term neurobehavioral consequences and possible 
molecular implications of prenatal Dex exposure in adult male offspring in rats. My results 
suggest that prenatal Dex exposure had no effect on HPA axis and behavioural responses to 
an acute stress, it however affected hippocampus and PFC-associated cognition in the adult 
male offspring.  
 
Despite previous reports that prenatal stress leads to stable changes in stress response systems 
and induces susceptibility to develop fear and anxiety-related behaviour after adult stress 
exposure, there is no evidence from my current study that prenatal Dex treatment affects the 
HPA axis and behavioural responsivities to stress in adult male offspring. Discrepancies in 
experimental findings may arise from variations in animal strain, prenatal stress regimen, age 
and sex of offspring and specific test conditions. It is interesting to note that despite using a 
same rat model my current elevated plus-maze and open field results contradicted with a 
previous study, where prenatally Dex-treated male rat offspring were found to have a trend 
towards decreased open arm entries on an elevated plus-maze and significantly decreased 
ambulation over a 12 min open field test (Welberg et al., 2001). In my current study there were 
no significant findings from the elevated plus-maze and possible contributing factors have 
been discussed in 3.4. In the open field test, my current data show a tendency towards increased 
ambulation in prenatally Dex-exposed rats, indicating potential dexamethasone programming 
effects on spontaneous locomotion in adult offspring, in line with most previous studies (Diaz 
et al., 1997, Wilson et al., 2013). The contradictory findings in an open field test between my 
current study and the Welberg study could be due to differences in aversiveness of the task 
such as illumination on the apparatus, and more importantly due to the protocol such as the 
period of time over which ambulation was examined (5 min in my experiment and 12 min in 
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the Welberg study). For example, there is evidence from previous study that prenatally stressed 
male rats exhibit decreased overall exploratory activity despite an higher initial activity in an 
open field (Poltyrev et al., 1996a). Overall, my current study does not support the hypothesis 
that prenatally Dex-exposed individuals are at increased risk of developing stress-related 
psychopathological changes in adulthood.  
 
My current results also suggest that prenatal Dex exposure in rats impairs the development of 
context-dependent fear conditioning in adult male offspring. Contextual fear conditioning 
depends on the neural circuit between the hippocampus and the amygdala (Rudy et al., 2004). 
There is evidence that hippocampal synapse activity is implicated in fear conditioning (Rao-
Ruiz et al., 2015). Thus, the impaired contextual fear conditioning in prenatally Dex-exposed 
animals could indicate potential deficits in hippocampal synapse function.  
 
In this thesis, cognitive flexibility is assessed by a) fear extinction in a contextual fear 
conditioning test; b) reversal learning and DMTP in a Morris water maze; and c) attentional 
set-shifting in an ID/ED test. The current data for fear extinction is inconclusive and future 
experiments are required to elucidate this further. The current results suggest that prenatally 
Dex-treated rats are faster in responding to changes in stimulus-reward associations in water 
maze tasks. Similar behavioural effects following prenatal Dex exposure have been reported 
in Marmosets (Callithrix jacchus, primates), in which late gestational Dex treatment induced 
enhanced reversal learning of stimulus-reward contingencies in adolescent monkeys (Hauser 
et al., 2008). In addition, the current results suggest prenatal Dex treatment facilitates 
behavioural flexibility on water maze tasks without affecting attentional shifts. Lesion studies 
in monkeys and rats suggest that different regions of the PFC mediate different aspects of 
cognitive flexibility, for example there is evidence lesions to the rat orbital prefrontal cortex 
produce deficits in reversal learning in the absence of deficits in shifting attentional sets 
(McAlonan and Brown, 2003, Dias et al., 1996). Thus, my current results may indicate 
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dissociable effects of prenatal Dex treatment on cognitive processing involved in different 
aspects of behavioural flexibility.  
 
As discussed in 4.4, the current results suggest that increased behavioural flexibility in 
prenatally Dex-exposed rats are not associated with memory deficits; instead it indicates 
deficits involving non-mnemonic processes such as attention and inhibitory control. Similar 
abnormalities are characterized in patients with psychiatric disorders such as ADHD (Barkley, 
1997), including impaired sustained attention (Berwid et al., 2005) and endogenous response 
control (van den Bergh et al., 2006). Interestingly, in one human study researchers investigated 
the cognitive consequences of maternal anxiety during pregnancy on adolescent performance 
on a matching-to-sample task. The adolescent offspring of mothers who had higher levels of 
gestational anxiety responded significantly faster, but with more errors, compared to the 
adolescent offspring of mothers who had lower levels of anxiety during pregnancy. Working 
memory, inhibition of a prepotent response (perseveration tendencies) and visual orienting of 
attention were not impaired between the two groups (Van den Bergh et al., 2005, Mennes et 
al., 2006). These cognitive outcomes are very similar to what I found in the current study, 
including no effect on working memory and attentional set-shifting and faster responding to 
changes in task-requirements in prenatally exposed individuals. The authors of the above-
mentioned human study suggest that the behavioural phenotype in adolescents exposed to 
higher antenatal maternal anxiety is indicative of impaired endogenous inhibitory control (Van 
den Bergh et al., 2005). In a follow up study, the same group of researchers suggest a link 
between antenatal maternal anxiety and impairments in sustained attention or self-regulation 
in adolescents (van den Bergh et al., 2006). It is however important to note that cognitive 
processes differ significantly between humans and animals, such that these results are not 
directly comparable. Overall although the prenatal Dex exposure rat model share some 
phenomenological similarities to related neuropsychiatric disorders, most of the results of the 
current set of experiments are not what we would have expected, and the validity of using this 
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animal model for studying risks and mechanisms of related human conditions needs to be 
further justified.  
 
7.2.2 Molecular results 
In this thesis, I also explored possible molecular mechanisms underlying the cognitive 
behavioural phenotypes induced by prenatal Dex treatment. As discussed in 5.1, brain GR and 
MR expression mediate complimentary but also in part overlapping actions in stress responses, 
memory and behavioural functions (Korte, 2001, de Kloet et al., 1999). In my current study, 
prenatally Dex-treated rats exhibited increased GR expression in the hippocampus and 
increased MR expression in the PFC. Behaviourally, offspring of stressed dams exhibited 
normal stress hormonal response, impaired fear conditioning and increased behavioural 
flexibility in the Morris water maze tests. It is hard to combine all the evidence and give a 
consistent explanation in terms of brain GR/MR expression and the associated behavioural 
findings. Possible confounding factors may include discrete function of GR/MR expression at 
specific regions of the brain, for example there is evidence that forebrain GR knockout is 
associated with impaired HPA axis feedback and increased anxiety-like behaviour, whereas 
amygdala-specific GR disruption is associated with deficient fear conditioning (Arnett et al., 
2011). In addition, any functional relevance of mRNA expression still depends on the actual 
level of protein translation and other molecular mechanisms may also take part in contributing 
to the behavioural phenotypes.  
 
My current study also highlighted a role of synaptic function in mediating prenatal 
glucocorticoid effects. Previous studies suggest that hippocampal synaptic plasticity is 
implicated in contextual fear conditioning (Rao-Ruiz et al., 2015) and synaptic plasticity 
within the hippocampus-to-PFC connection is associated with PFC-dependent task 
performance (Cerqueira et al., 2007). In fact, there is evidence that prenatal stress impairs 
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hippocampal synaptic function in the adult offspring, associated with spatial learning deficits 
in the Morris water maze (Yang et al., 2006, Son et al., 2006). In my study, there was an 
increased baseline expression of Egr1 and Arc in the adult brain of prenatally Dex-treated rats, 
together with impaired fear-related memory retention and enhanced behavioural learning and 
flexibility in Morris water maze tasks. Although there is evidence that resting levels of Arc 
transcription are associated with memory consolidation and retrieval (Penner et al., 2011), it 
is the activity-dependent IEGs induction that produces stable changes in synaptic strength, 
which is associated with behavioural learning and flexibility. Within the current data sheet it 
is hard to predict how an increased resting levels of IEGs expression might affect synaptic 
plasticity and contribute to the behavioural phenotypes during training.  
 
In this thesis I also found altered imprinted gene expression profile in the adult hippocampus 
of prenatally Dex-exposed rats. However too little is still known about the function of 
imprinted genes in the adult brain, and brain-expressed imprinted genes seem to have disparate 
roles in the brain in addition to their common roles in the peripheral system (Garfield et al., 
2011). It is therefore not yet possible to draw any conclusion on the behavioural implications 
of altered imprinted gene expression in the brain. Interestingly however, my results revealed 
increased L1 transcription in the adult brain of prenatally Dex-exposed animals. L1 expression 
was not increased in the E20 frontal lobe of the Dex-treated embryos, suggesting that prenatal 
Dex exposure induces susceptibility to increased L1 transcription in adults. Increased 
retrotransposon activities may endanger the integrity of the genome, and have been implicated 
in the pathogenesis of schizophrenia (Bundo et al., 2014).  
 
Overall my current molecular results provide evidence that prenatal Dex exposure may 
interfere with synaptic development and retrotransposon activities in the offspring, leading to 
permanent alterations in synaptic strength and brain function, and thus inducing increased risk 
for neuropsychiatric disorders in later life. Further investigations into these molecular 
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processes may provide insights into the mechanisms through which prenatal environment 
evokes an impact on future mental health. 
 
7.2.3 Prenatal programming and adaptations 
Finally, the results of my current study again bring into focus the controversy of adaptive and 
maladaptive effect of prenatal programming. The current data suggest that prenatal Dex 
exposure induces impaired fear conditioning in the offspring. For animals living in the wild a 
failure to consolidate the fear memories of a predator's appearance, smell and location is 
apparently a disadvantage, which could result in a failure to predict and prevent future 
encounters with the predator, and thereby reduce the likelihood of survival. In addition, 
prenatally Dex-exposed rats show faster responding to changes in task-requirements on water 
maze tasks. Although this phenotype may associate with deficits in attention and inhibitory 
control, it is potentially an advantage to survive in a hazardous and ever-changing 
environment. This evidence lends support to the match-mismatch hypothesis, such that an 
individual who has been exposed to an aversive in utero environment is programmed to 
‘expect’ an unfavourable environment after birth; if the later environment turns out to be 
challenging, the programmed traits can thus become a privilege (Nederhof and Schmidt, 
2012). Overall my current results suggest that the outcome of early life programming is not 
always deleterious, and the pros and cons of prenatal programming are better to be evaluated 
in the context of both the individual and the current environment. 
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7.3 Future work 
7.3.1 Behavioural experiments 
In this thesis, I found no evidence of prenatal Dex treatment effects on basal and stress-induced 
plasma CORT levels 15 min after exposure to an acute stress. Previous studies suggest that 
prenatal stress may not affect basal or peak CORT levels after a stress exposure; it however 
induces prolonged CORT secretion and the elevated CORT levels 2 hr after stress exposure 
(Maccari et al., 2003, Henry et al., 1994, Vallee et al., 1997, Koenig et al., 2005). There is also 
evidence that prenatal stress affects hormone adaptation after repeated exposure to stress 
(Fride et al., 1986). It would thus be interesting to study the potential effect of prenatal Dex 
exposure on hormone adaptations such as the time-course of stress-induced hormone secretion 
after an acute and repeated stress. In addition, it might be interesting to look at other 
biochemical indicators of HPA axis function. For example, there is evidence prenatal stress 
leads to increased secretion of overall HPA axis hormones including circulating 
adrenocorticotropic hormone (ACTH) and CORT (Takahashi and Kalin, 1991).  
 
In terms of fear and anxiety-related behaviour, I have shown that prenatal Dex exposure had 
no effect on unconditioned fear and anxiety-related behaviour; however it affected fear-related 
memory consolidation in the adult male offspring. In future it would be interesting to explore 
other aspects of fear and anxiety-related behaviour, for example, fear potentiation and fear 
extinction. Fear potentiation is interesting because a) there is evidence that prenatal stress leads 
to decreased innate fear (Wilson et al., 2013), which may affect an animal’s emotional 
evaluation of a stressful situation and may interfere with measures that depend on innate fear 
responses and b) there is evidence that prenatal stress induces behavioural differences only on 
a fear-potentiated, but not unconditioned elevated plus-maze and open field in rats (Estanislau 
and Morato, 2005, Poltyrev et al., 1996b). In terms of fear extinction, there is evidence that 
variable prenatal stress and restraint stress to pregnant dams induces impaired fear extinction 
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in adult rat offspring (Green et al., 2011b, Markham et al., 2010). It is therefore possible that 
prenatal Dex administration to pregnant dams might also have an effect on behavioural 
adaptation of conditioned fear in adult offspring.  
 
In terms of the current water maze and ID/ED results, prenatal Dex treatment had no effect on 
attentional set-shifting, it however facilitated behavioural flexibility on water maze tasks 
involving non-mnemonic processes. The brain regions that have been mapped to the cognitive 
phenotype mentioned above include cortical and sub-cortical regions linked to the 
orbitofrontal cortex (Mennes et al., 2006, McAlonan and Brown, 2003). It would be interesting 
in future studies to explore prenatal Dex treatment effects on other cognitive aspects related to 
orbitofrontal cortex function. In addition, future experiments would enable us to dissociate 
potential contributions of attention and inhibitory control to the increased flexibility on water 
maze tasks. Possible experiments include a redial arm maze (Bimonte and Denenberg, 2000), 
a 5-choice serial reaction time task (Asinof and Paine, 2014), a two-choice operant task 
(Adriani et al., 2010) and a delay-discounting task (Evenden and Ryan, 1996).  
 
Finally, it may be worth to consider possible postnatal maternal behaviour influence on 
prenatal programming. Some previous studies suggest that the prenatal programming effects 
are independent of postnatal maternal behaviour (Nyirenda et al., 2001, Holloway et al., 2013). 
By contrast, there is evidence that cross fostering by a control mother can reverse the effect of 
prenatal treatment on HPA axis activity and spatial learning (Maccari et al., 1995, Brabham et 
al., 2000), whereas cross fostering by a stressed mother can exacerbate the prenatal effects on 
offspring (Francis et al., 1999, Kuo et al., 2014). A cross-fostering paradigm in future studies 




7.3.2 Molecular experiments 
In this thesis, I have shown that prenatal Dex exposure induced altered basal-state expression 
of candidate genes implicated in synaptic plasticity in the brain. There is evidence that synaptic 
plasticity is implicated in prenatal stress induced learning deficits (Yang et al., 2006) as well 
as human neuropsychiatric disorders such as schizophrenia (Hall et al., 2015). Given the role 
of genes such as Arc in plasticity and learning this would be a particularly interesting future 
avenue of investigation.  
 
It has been reported that Arc mRNA is accumulated at the dendrites of stimulated neurons 
(Lyford et al., 1995). Its transcription is induced by neural activity specifically associated with 
active information processing, such that cellular imaging of Arc induction has become a robust 
method for detecting neural networks engaged by discrete behaviours (Guzowski et al., 2005). 
There is also evidence that the level of Arc transcription induced by behaviour training is 
associated with animal performance and behavioural flexibility (Guzowski et al., 2001). In 
response to neural activity, Arc mRNA is transported to dendrites and becomes enriched at the 
site of local synaptic activity, where ARC protein is locally synthesized. Translation of ARC 
protein at active synapses is considered the molecular basis for stabilising activity-dependent 
changes in synaptic efficacy that underlies learning and memory formation (Robertson, 1992). 
There is evidence that suppression of ARC protein translation impairs long-term memory 
consolidation without affecting task acquisition and short-term memory (Guzowski, 2002). On 
the other hand, over-accumulation of ARC leads to concomitant decrease in the number of 
glutamate receptors at excitatory synapses, which impairs synapse function and contributes to 
the cognitive impairments in human patients (Greer et al., 2010).  
 
My current study shows an increased Arc mRNA in the adult brain of prenatally Dex-treated 
rats at resting conditions. In future it would be of interest to determine whether prenatal Dex 
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exposure alters the activity-dependent Arc induction after behaviour training. In fact, to fully 
character the prenatal Dex effects on Arc regulation and synaptic function, it is essential to 
decide the precise kinetics of Arc mRNA transcription and local protein translation at distal 
synapses, as well as Arc mRNA intracellular trafficking within the neuronal processes, ideally 
calls for fluorescence in situ hybridisation combined with quantitative methods such as RT-
PCR in future studies.  
 
In addition, my current study revealed increased L1 transcription in the adult brain of 
prenatally Dex-exposed rats. It is possible that increased L1 transcription might associate with 
increased retrotransposition events, which can be confirmed by increased L1 copy numbers in 
the genomic DNA. It would in addition be of interest to see if alterations in L1 activities are 
regulated by epigenetic mechanisms such as DNA methylation. Essays have been developed 
for measuring global L1 methylation levels using MethyLight (Weisenberger et al., 2005). It 
would also be of interest to investigate L1 activities and methylation profiles in the peripheral 
tissues and blood cells as potential biomarkers for neuropsychiatric disorders.   
 
Finally, I have discussed in this thesis that stable epigenetic marks acquired during 
developmental time may serve as archives of early exposures with potential to improve our 
knowledge of the mechanisms of fetal origins of adult disease. Although my current study 
didn’t provide direct evidence that epigenetics is involved in mediating the long-term effects 
of prenatal Dex exposure, future studies on epigenetic patterns of the brain after prenatal 
exposure to stress have a potential for identifying how environmental experiences or 
challenges evoke life-long impact on behaviour, brain function and disease susceptibility.  
 
. 
In summary, my current study provides evidence that prenatal exposure to stress hormones 
has complex effects on later behaviour and brain gene expression. My study also suggests a 
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role of synaptic function and retrotransposon activities in mediating the long-term impact of 
prenatal glucocorticoid exposure on mental health. Thus, prenatal exposure to glucocorticoids 
may have programming effect on synaptic development and retrotransposon activities that 
permanently affect brain function and behaviour, and thus leading to increased susceptibility 
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Sigma-Aldrich Ltd., Dorset, UK Water (Molecular Biology Reagent) 
 Sodium acetate  
 Hydrogen peroxide solution 
 Ethylenediaminetetraacetic acid disodium salt 
dihydrate 
 Diethyl pyrocarbonate 
 2-Mercaptoethanol 
 Antifoam A Concentrate 
 Guanidine thiocyanate  
 N-Lauroylsarcosine sodium salt 
 Trizma® base 
 Phenol solution pH 4.3 ± 0.2 
 Chloroform-isoamyl alcohol mixture 
VWR International, Leicestershire, UK Ethanol 
 Isopropanol 
Bioline, London, UK Agarose powder 
Biotium Inc., California, USA Gel-Red™ nucleic acid stain 
Promega Ltd., Southampton, UK RQ1 RNase-Free DNase 
 RQ1 DNase 10 Reaction Buffer 
 RQ1 DNase Stop Solution 
Qiagen, West Sussex, UK RNeasy®  Mini Kit 
 RNeasy®  Plus Mini Kit 
 DNeasy® Blood & Tissue Kit  
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 Multiplex PCR Kit 
 PyroMark Q24 Gold Reagents (5 x 24) 
 PyroMark Annealing Buffer 
 PyroMark Binding Buffer  
 PyroMark Wash Buffer  
 PyroMark Denaturation Solution 
Invitrogen, Glasgow, UK Customer Primers 
 Qubit® RNA HS Assay Kits 
 Qubit® dsDNA HS Assay Kits 
 PureLink™ RNase A  
 100bp DNA ladder 
Applied Biosystems, Warrington, UK TaqMan™ Gene expression assay 
 AmpliTaq® Gold PCR Master Mix 
 High-Capacity cDNA Reverse Transcription 
Kit with RNase Inhibitor 
GE Healthcare Life Sciences, Sweden Streptavidin Sepharose™ High Performance 
Roche Diagnostics Ltd., West Sussex, UK LightCycler 480 Probes Master 
 Universal Probe Library Probes 
Zymo Research, Irvine, USA EZ DNA Methylation™ Kit 




Agilent Technologies, Cheshire, UK Agilent 2100 Bioanalyzer system 
Bio-Rad Laboratories Ltd., Hertfordshire, 
UK 
Power Pack 200 agarose gel system 
EMD Millipore Milli-Q integral water purification system 
Eppendorf, Cambridge, UK 5424 Bench centrifuge  
5415R Bench centrifuge  
Grant bio LMC-3000 laboratory centrifuge 
G-Storm Ltd., Somerset, UK GS-1 Thermo Cycler 
Invitrogen, Paisley, UK Qubit® 2.0 Fluorometer 
PRO Scientific, Connecticut, USA PRO200 Homogeniser 
Qiagen, West Sussex, UK PyroMark Q24 system 
Roche Diagnostics Ltd., West Sussex, UK Roche® 480 Light Cycler 





Agilent 2100 Bioanalyzer  2100 Expert Software (Agilent Technologies)  
Fear conditioning FreezeFrame software (Coulbourn Instruments, USA) 
LightCycler 480 LightCycler 480 release 1.5 O SP3 (Roche)  
Morris water maze Water maze software (Tracker- P. Spooner) 
PyroMark Q24  PyroMark Assay Design 2.0 software (Qiagen) 
PyroMark Q24 analysis software (Qiagen) 
Statistics JMP statistical software (SAS Institute, USA) 
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